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Chair: James P. Simmer 
 
For the past decades, tooth development has been extensively studied as a model for 
understanding organogenesis of ectoderm-derived structures. Much has been learned from the 
morphological patterning and molecular signaling of normal tooth development in model 
organisms, mainly rodents. On the other hand, human inherited dental anomalies also provide a 
valuable source for studying tooth development. Discerning the genetic etiology of these 
developmental defects not only enhances our understanding of normal tooth development but 
also provides a fundamental basis for developing potential therapeutic strategies for these 
disorders. 
Familial tooth agenesis (FTA) and amelogenesis imperfecta (AI) are the two most 
prevalent inherited dental defects in humans, characterized by failed tooth development and 
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dental enamel malformations respectively. In this dissertation research, we described 7 FTA and 
12 AI families and aimed to define the genetic etiology of the diseases through mutational 
analyses. By using target gene approaches and whole exome analyses, we successfully identified 
the disease-causing mutations in 2 FTA families and in all the AI cases. The results not only 
expanded the mutation spectrum of known disease-associated genes but also established novel 
candidate genes, revealing critical players in tooth and enamel development. 
Nevertheless, although human genetic studies of inherited dental and enamel defects have 
revealed many genes associated with the diseases, the functions of many of these genes and their 
roles in normal development and pathological conditions remain to be elucidated. Recently, 
mutations in FAM83H (family with sequence similarity 83, member H) were identified to cause 
autosomal dominant hypocalcified amelogenesis imperfecta (ADHCAI). Although many 
disease-causing FAM83H mutations have been reported, the cellular functions of this gene and 
the pathogenesis of its associated enamel defects are completely unknown. In this study, we used 
a biochemical approach to study FAM83H protein-protein interactions and identified CK1 
(casein kinase 1) and SEC16A as FAM83H interacting proteins, which indicated a potential 
cellular function of FAM83H in vesicle trafficking and protein transport. The results also 
provided an explanation for the high mutation homogeneity of FAM83H disease-causing 
mutations revealed by human genetic studies and suggested a potential pathological mechanism 







During evolution, mammals, compared to ancestral vertebrates, have lost a significant 
capacity for tooth renewal (Jernvall and Thesleff, 2012). In humans, only two sets of dentitions 
develop during a lifetime. Therefore, for the past decades, significant efforts have been made to 
regenerate teeth for replacement of missing teeth (Young et al., 2002; Sharpe and Young, 2005; 
Ikeda and Tsuji, 2008; Ikeda et al., 2009). However, the way to achieve this ultimate goal of 
regenerative dentistry greatly depends upon our thorough comprehension of tooth development 
in which the genetic control of this developmental process has not yet been completely 
understood. 
Most of our current knowledge regarding the cellular and genetic basis of tooth 
development has come from mouse studies. Extensive investigations in molecular regulation of 
tooth formation have been carried out with many genetically engineered mouse models 
(Fleischmannova et al., 2008; Bei, 2009). In addition, mutational analysis for human 
developmental tooth defects has further provided more relevant insight into tooth development in 
humans (Cobourne and Sharpe, 2013). For example, the identification of MSX1 mutations as a 
cause of human tooth agenesis (congenitally missing teeth) demonstrates a critical role of this 
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transcription factor in early tooth development (Vastardis et al., 1996). Along the same line, 
discerning the genetic defects causing inherited dental anomalies, such as hereditary enamel and 
dentin defects, will significantly improve our understanding of the normal developmental 
processes during tooth formation. 
Familial tooth agenesis, amelogenesis imperfecta (inherited enamel defects), and 
dentinogenesis imperfecta (inherited dentin defects) are so far the three most extensively-studied 
developmental tooth defects (Kim and Simmer, 2007; Nieminen, 2009; Chan et al., 2011; 
Cobourne and Sharpe, 2013). Many genes have been shown to be associated with these 
conditions and to be critical for specific processes of tooth development. However, the genetic 
etiologies of many cases of these diseases and many other inherited dental defects, such as 
hyperdontia (formation of extra teeth) and microdontia (small-sized teeth), have not yet been 
defined, revealing our current incomplete knowledge about tooth development (Cobourne and 
Sharpe, 2013). 
Furthermore, in spite of the great impact of human mutational analysis on discovering 
critical players in tooth development, the functions of many genes identified from human genetic 
studies have been largely unknown. For example, our group identified FAM83H mutations as the 
cause of autosomal dominant hypocalcified amelogenesis imperfecta (ADHCAI), demonstrating 
a significant role of this gene in dental enamel formation (Kim et al., 2008). Although 20 
different FAM83H mutations have been so far reported (Wang et al., 2013), the molecular 
functions of FAM83H and its role in enamel formation are completely unknown. Also, how 
mutations in FAM83H lead to the enamel defects is still an open question. Therefore, the need 
for functional studies of specific genes discovered by human mutational analysis of inherited 




Our group has been working, for more than a decade, on mutational analysis of various 
human hereditary dental anomalies, including tooth number abnormalities, inherited enamel and 
dentin defects. Among these disorders, familial tooth agenesis and amelogenesis imperfecta are 
the two that we have recruited more families with and studied more extensively. However, the 
genetic causes of many cases of these two diseases are still to be identified (Chan et al., 2011). 
We hypothesized that by defining the genetic etiology in these cases through mutational analysis, 
we would be able to expand the mutational spectrum in known disease candidate genes and 
discover novel candidate genes. 
Furthermore, as mentioned previously, our group identified the genetic defects of 
ADHCAI in a novel gene, FAM83H, of which the molecular functions are completely unknown. 
We hypothesized that by molecularly characterizing FAM83H protein, we would gain insight 
into its cellular function in enamel formation and the pathological mechanism of ADHCAI 
caused by FAM83H mutations. 
 
SPECIFIC AIMS 
Two specific aims are proposed to test the hypotheses: 
SA 1 To define the genetic etiologies of familial tooth agenesis and amelogenesis imperfecta 
Dr. Jan Hu has recruited families with familial tooth agenesis (congenital missing teeth) 
and amelogenesis imperfecta (inherited enamel defects). By conducting mutational analysis with 
target gene approaches and whole exome sequencing, we aim to identify disease-causing 
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mutations in these families. Many candidate genes have been reported to cause these two 
diseases. By accomplishing this specific aim, we expect to find novel mutations in known 
candidate genes and probably discover new disease-associated genes. 
 
SA 2 To molecularly characterize FAM83H protein in vitro 
Instead of being directly cloned from developing teeth, FAM83H was discovered with 
mutational analysis through a genome-wide search (Mendoza et al., 2007; Kim et al., 2008). The 
primary structure of FAM83H, a protein of 1179 amino acids in humans, gives little indication of 
its potential functions. However, it has no obvious signal peptide and is expected to be a non-
secretory protein, which is distinct from the known enamel matrix proteins, such as amelogenin, 
ameloblastin, and enamelin. This uniqueness of intracellular localization of FAM83H implies its 
potential intracellular function rather than extracellularly-structural function of all the other 
enamel proteins. By conducting protein-protein interaction studies, we aim to define the protein 
interactome of FAM83H, identify FAM83H-binding partners which may provide insights into its 
intracellular functions, and characterize potential functional domains of FAM83H protein. By 
accomplishing this specific aim, we expect to know which physiological cellular processes 
FAM83H may be involved in and probably to unravel the pathological mechanism of FAM83H-
associated enamel defects. 
 
BACKGROUND AND SIGNIFICANCE 
Early tooth development 
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Tooth development, like that of all the other ectodermal appendages, is a sequential process of 
reciprocal epithelial-mesenchymal interactions that involves intricate modulation of complex 
signaling pathways (Bei, 2009; Thesleff, 2013). Morphologically, tooth formation commences 
with a structure of dental epithelial thickening, the dental lamina, which subsequently 
proliferates and invaginates into underlying mesenchyme. At the same time, signals from 
thickened epithelium induce condensation of mesenchymal cells, which is recognized as a tooth 
germ. The condensed mesenchyme then guides further epithelial invagination and convolution to 
progress the enamel organ through the sequential bud, cap, and bell-shaped stages of tooth 
morphogenesis. During these stages, distinct anatomical and functional parts of the tooth form, 
and the basic shape of tooth crown is established. Eventually, the mesenchyme-derived 
odontoblasts and epithelium-derived ameloblasts differentiate at the epithelial-mesenchymal 
 
 
Figure 1.1: The process of tooth development. 
The dental placode and enamel knots are signaling centers regulating tooth morphogenesis. This image is 
reproduced from Figure 1 of reference (Thesleff I. Current understanding of the process of tooth 
formation: transfer from the laboratory to the clinic. Aust Dent J 2013, Epub ahead of print) by 
permission of John Wiley & Sons Inc. 
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interface to form dentin and enamel respectively (Fig. 1.1) (Tucker and Sharpe, 2004; Nanci, 
2008a; Thesleff, 2013). 
Many genes and signaling pathways have been demonstrated to regulate morphological 
patterning and cell differentiation at specific stages of tooth development. Members of the 
transforming growth factor β (TGFβ), fibroblast growth factor (FGF), sonic hedgehog (Shh) and 
Wnt signaling pathways constitute the key pathways that mediate epithelial-mesenchymal 
interactions during tooth development (Fig. 1.2) (Jernvall and Thesleff, 2000; Bei, 2009; 
Tummers and Thesleff, 2009; Thesleff, 2013). Animal studies have shown that aberration of any 
of these pathways leads to developmental arrest of teeth at early stages of tooth formation 
(Fleischmannova et al., 2008; Bei, 2009). For example, conditional inactivation of Shh in the 
dental epithelium results in the arrest of tooth development at the bud stage (Dassule et al., 
2000). Furthermore, transcription factors mediating these signaling networks are critical for early 
tooth development as well. Both Msx1 and Pax9 null mice exhibit failed tooth formation 
(Satokata and Maas, 1994; Peters et al., 1998). In humans, environmental or genetic disturbances 
during the early process of tooth development also lead to the developmental arrest of tooth 
germs and cause tooth agenesis (De Coster et al., 2009; Parkin et al., 2009). 
 
Familial tooth agenesis 
Familial tooth agenesis refers to the inherited failure of teeth to develop. It is the most 
prevalent craniofacial anomaly in humans (Parkin et al., 2009; Nieminen, 2009). Both the 
primary (deciduous) and secondary (permanent) dentitions may be affected, with a higher 
prevalence of the later. In addition, the number and class of teeth involved may vary 
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Figure 1.2: Signaling 
pathways and molecules 
critical for tooth 
development. 
Teeth form from oral 
epithelium (green) and 
underlying mesenchyme 
(blue) and interactions 
between these tissues 
regulate development. The 
most important signal 
molecules mediating this 
communication are BMP (bone morphogenetic protein), WNT, SHH (sonic hedgehog) and FGF 
(fibroblast growth factor). They regulate the expression of important transcription factors indicated in 
boxes. Loss of function of many of these genes arrests the process of tooth development in genetically 
modified mice, and their mutations cause tooth agenesis in humans. This image is reproduced from Figure 
2 of reference (Thesleff I. Current understanding of the process of tooth formation: transfer from the 
laboratory to the clinic. Aust Dent J 2013, Epub ahead of print) by permission of John Wiley & Sons Inc. 
 
significantly, with considerable demographic and geographic variations. Different patterns of 
disease inheritance and penetrance have also been described, with autosomal dominant pattern 
being the most common mode of inheritance.  Several terms have been used to describe tooth 
agenesis with various disease severities. “Hypodontia” has been used as a general term for 
congenitally missing teeth but currently refers to a specific condition with less than six missing 
teeth. “Oligodontia” and “anodontia” are used to describe more severe forms of at least six teeth 
missing and complete lack of teeth respectively (Nieminen, 2009). These terms can refer to 
isolated disorders in the absence of non-dental phenotypes but can also be used to indicate 
manifestations in syndromes, such as ectodermal dysplasia. Although most of the cases of tooth 
agenesis are isolated (non-syndromic), many developmental syndromes include hypodontia as 
part of their phenotypic anomalies, more than 60 of which are listed in Online Mendelian 
Inheritance in Men (OMIM) (Cobourne, 2007; Cobourne and Sharpe, 2013). 
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Genetic defects in a number of genes have been reported to cause non-syndromic tooth 
agenesis, including MSX1 (Msh homeobox 1) (STHAG1; MIM #106600) (Vastardis et al., 
1996), PAX9 (paired box 9) (STHAG3; MIM #604625) (Stockton et al., 2000), EDA 
(ectodysplasin A) (STHAGX1; MIM #313500) (Tao et al., 2006), and WNT10A (Wingless-type 
MMTV integration site family, member 10A) (STHAG4; MIM #150400) (Bohring et al., 2009). 
In addition, mutations in AXIN2 (axis inhibition protein 2) and LTBP3 (latent transforming 
growth factor beta binding protein 3) respectively lead to oligodontia-colorectal cancer syndrome 
(MIM #608615) (Lammi et al., 2004) and selective tooth agenesis (MIM #613097) (Noor et al., 
2009), in which the affected individuals have tooth agenesis with variable expressivity of other 
non-dental manifestations. MSX1 and PAX9 are two transcription factors shown to be expressed 
at dental mesenchyme throughout all the stages of odontogenesis (Tummers and Thesleff, 2009). 
Both Msx1 and Pax9 null mice exhibit developmental arrest of teeth at bud stage with abolished 
mesenchymal expression of BMP4 (bone morphogenic protein 4), a morphogen critical for tooth 
development (Satokata and Maas, 1994; Peters et al., 1998). EDA is a member of tumor necrosis 
factor (TNF) superfamily and involved in NF-κB signaling pathway, which is essential for 
ectodermal organogenesis (Mikkola and Thesleff, 2003). EDA mutations contribute to the human 
X-linked hypohidrotic ectodermal dysplasia, which is featured by EDA triad, hypotrichosis, 
hypodontia, and hypohidrosis (Kere et al., 1996). However, affected hemizygous females 
sometimes only show congenital absence of teeth without other non-dental phenotypes, making 
EDA a candidate gene for isolated tooth agenesis (Tao et al., 2006). Genetic defects of WNT10A 
were first identified to cause Odontoonychodermal dysplasia (OODD; MIM#257980), a rare 
autosomal recessive syndrome characterized by features of ectodermal dysplasia, including 
severe oligodontia (Adaimy et al., 2007). However, it was recently reported that people carrying 
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heterozygous WNT10A mutations are prone to have tooth agenesis with no other OODD 
characteristics (Bohring et al., 2009). These findings reaffirm the critical role of Wnt signaling in 
tooth development, which has been demonstrated in many mouse models (Fleischmannova et al., 
2008; Bei, 2009). Furthermore, another player of the Wnt signaling pathway, AXIN2, is also 
associated with tooth agenesis. However, it is worth noting that people with AXIN2 mutations 
have not only severe oligodontia but also a predisposition to colorectal cancers (Lammi et al., 
2004). As TGFβ signaling has been known to be important for tooth development, homozygous 
LTBP3 mutations were found in a family with oligodontia and short stature with increased bone 
density (Noor et al., 2009). In addition to these genes associated with isolated tooth agenesis, 
many others are found in syndromic tooth agenesis, such as PITX2 and IKBKG (NEMO), which 
reveals more critical players in early tooth development (Cobourne and Sharpe, 2013). 
 
Enamel development (amelogenesis) 
Dental enamel is the most highly mineralized tissue in human bodies, comprised of more 
than 96% calcium hydroxyapatite crystallites. Its hardness and strength come from not only the 
high mineral content, but also the highly-ordered organization of enamel crystallites. Therefore, 
dental enamel formation, amelogenesis, requires an intricately regulated orchestration of cellular 
and chemical events during the process to properly make enamel with the necessary mineral 
composition and organization (Smith, 1998, Simmer et al., 2010). Environmental disturbances or 
genetic aberrations in this process will lead to developmental enamel defects (Winter and Brook, 




Figure 1.3: Ameloblast changes during enamel formation. 
The epithelial cells of the inner enamel epithelium (1) rest on a basement membrane containing laminin. 
These cells increase in length as differentiating ameloblasts above the predentin matrix (2). Presecretory 
ameloblasts send processes through the degenerating basement membrane as they initiate the secretion of 
enamel proteins on the villous surface of mineralizing dentin (3). After establishing the dentinoenamel 
junction and mineralizing a thin layer of aprismatic enamel, secretory ameloblasts develop a secretory 
specialization, or Tomes’ process. Along the secretory face of the Tomes’ process, in place of the absent 
basement membrane, secretory ameloblasts secrete proteins at a mineralization front where the enamel 
crystals grow in length (4). Each enamel rod follows a retreating Tomes’ process from a single 
ameloblast. At the end of the secretory stage, ameloblasts lose their Tomes’ process and produce a thin 
layer of aprismatic enamel (5). At this point the enamel has achieved its final thickness. During the 
transition stage, the ameloblasts undergo a major restructuring that diminishes their secretory activity and 
changes the types of proteins secreted (6). KLK4 is secreted, which degrades the accumulated protein 
matrix and amelotin (AMTN) is secreted as part of the new basement membrane. During the maturation 
stage ameloblasts modulate between ruffled and smooth-ended phases (7). Their activities harden the 
enamel layer by promoting the deposition of mineral on the sides of enamel crystals laid down during the 
secretory stage. The histology of the developing tooth is adapted from Uchida et al. [1991]. This image is 
reproduced from Figure 1 of reference (Hu JC, Chun YH, Al Hazzazzi T, Simmer JP (2007). Enamel 
formation and amelogenesis imperfecta. Cells Tissues Organs 186:78-85.) by permission of S. Karger 
AG, Medical and Scientific Publishers. 
 
Enamel development can be divided into four stages, which is defined by the morphology 
and function of ameloblasts, the enamel forming cells (Fig. 1.3) (Hu et al., 2007). They are 
presecretory, secretory, transition, and maturation stages. After early morphogenesis of tooth 
development is complete, a layer of epithelial cells adjacent to underlying mesenchyme (inner 
enamel epithelium) starts to differentiate into ameloblasts. These cells gradually elongate in 
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morphology and reverse the cell polarity with nuclei facing away from the mesenchyme. At the 
same time, the differentiating cells, preameloblasts, extend cytoplasmic projections through the 
basement membrane, which is gradually degraded and removed. This presecretory stage prepares 
a proper environment for active matrix and ion deposition in subsequent stages of amelogenesis. 
During the secretory stage, the tall columnar ameloblasts secrete large amounts of enamel matrix 
proteins (amelogenin, ameloblastin, and enamelin), and the enamel crystallites form, in 
association with the secreted proteins. At the same time, ameloblasts retreat from the 
dentinoenamel junction (DEJ) to allow extension of crystal ribbons (appositional growth), which 
establishes the thickness of the enamel. Once the enamel reaches its full thickness, the secretory-
stage ameloblasts retract their cytoplasmic processes and shorten into transition-stage 
ameloblasts, under which a basement membrane reforms. Subsequently, the transition-stage 
ameloblasts further transform into short cuboidal maturation-stage ameloblasts, which start 
modulating between ruffle and smooth-ended cells at the enamel surface. During the maturation 
stage, the enamel matrix proteins are further degraded by enamel proteases, mainly by kallikrein-
related peptidase 4 (KLK4) and less by matrix metalloproteinase 20 (MMP20), and are removed 
to provide space for ion deposition onto the sides of enamel crystallites (enamel maturation), 
which establishes the hardness of the enamel (Fig. 1.3) (Simmer and Fincham, 1995; Smith, 
1998; Fincham et al., 1999; Hu et al., 2007; Nanci, 2008b; Simmer et al., 2010; Bartlett, 2013). 
As mentioned previously, these developmental processes are intricately regulated and, therefore, 
highly susceptible to environmental or genetic influences. 
 
Amelogenesis imperfecta (AI) 
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Amelogenesis imperfecta (AI) is a group of inherited disorders characterized by enamel 
malformations typically in the absence of non-dental phenotypes (isolated AI). The term is also 
used to describe the enamel defects in syndromes (syndromic AI) (Witkop, 1988; Hu et al., 
2007). The prevalence of AI significantly varies geographically, ranging from 1:14,000 (U.S.A.) 
to 1:700 (North Sweden), depending on various populations (Witkop and Sauk, 1976; Witkop, 
1988). In addition, the disorder exhibits a great variability in disease phenotypes, which is 
classified according to the thickness, hardness and smoothness of the affected enamel (Witkop, 
1988; Aldred et al., 2003; Hu et al., 2007). Variations in these parameters are believed to result 
from differences in the timing of disturbances during amelogenesis. As the final thickness of 
dental enamel is established at secretory stage, disruption of this process will lead to insufficient 
enamel appositional growth and pathologically thin or hypoplastic enamel (hypoplastic AI). On 
the other hand, the maturation stage of amelogenesis is critical for development of enamel 
hardness. Aberration of this process will cause insufficient mineral deposits on the sides of 
enamel crystallites and leave enamel pathologically soft, a condition known as hypomaturation 
AI. In this case, the affected enamel is of normal thickness but easily abraded after tooth eruption 
due to the hardness defect. Hypocalcified AI is another form of AI in which the failure in 
mineralization is the most extreme. The enamel may have normal thickness but is rough, soft, 
and easily chipped off from tooth surfaces. Patients with AI often experience difficulty chewing 
and maintaining oral hygiene, have lower self-esteem due to poor dental appearance, and report 
compromised quality of life (Coffield et al., 2005). 
Defects in a number of genes have been reported to cause isolated AI, including AMELX, 
ENAM, KLK4, MMP20, FAM83H, WDR72, C4orf26, SLC24A4, and LAMB3 (Aldred et al., 
1992; Rajpar et al., 2001; Hart et al., 2004; Kim et al., 2005; Kim et al., 2008; El-Sayed et al., 
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2009; Parry et al., 2012; Parry et al., 2013; Poulter et al., 2013). In addition, many other genes 
have been shown to be associated with developmental syndromes with enamel defects, such as 
DLX3, CNNM4, ROGDI, FAM20A, STIM1, and ORAI1 (Cobourne and Sharpe, 2013). These 
findings reveal many critical players in dental enamel formation. AMELX (amelogenin) and 
ENAM (enamelin) are two genes encoding enamel matrix proteins that are actively secreted by 
ameloblasts at secretory stage. Mutations in these two genes lead to hypoplastic forms of AI (Hu 
et al., 2007). MMP20 and KLK4 are two major enamel proteases expressed by mainly secretory-
stage and maturation-stage ameloblasts respectively. While MMP20 processes enamel matrix 
proteins during the secretory stage, KLK4 is responsible for further degradation of residual 
proteins during the maturation stage (Hu et al., 2007; Bartlett, 2013). Mutations in these two 
genes generally cause enamel hardness defects (hypomaturation AI) due to defective protein 
degradation and removal (Hu et al., 2007). Except the four genes encoding enamel matrix 
proteins and proteases, all of the other AI associated genes were identified through human 
mutational analysis of AI kindreds (Kim et al., 2006; Chan et al., 2011). Therefore, the functions 
of most of these genes in enamel formation are largely unknown and under investigation, 
although some of them can be implied and predicted based upon limited current knowledge of 
the genes. 
 
FAM83H mutations and autosomal dominant hypocalcified AI (ADHCAI) 
Autosomal dominant hypocalcified AI (ADHCAI) is a specific form of AI in which the 
affected enamel is cheesy-soft and easily lost soon after tooth eruption (Witkop, 1988). Full 
thickness of enamel can only be seen on unerupted teeth from a radiograph or on erupting teeth 
without much attrition. The surface of enamel is rough and usually with brown-yellow 
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discoloration. Many efforts had been made to determine the genetic etiology of ADHCAI. 
However, target gene approaches failed to identify genetic defects in any of the known AI 
candidate genes encoding enamel matrix proteins and proteases (Kim et al., 2006). In 2008, by 
linkage analysis and a gene-by-gene screening, our group identified FAM83H mutations as a 
cause of ADHCAI (Kim et al., 2008). 
FAM83H (family with sequence similarity 83, member H) is a gene that was first 
identified through bioinformatics prediction in Human Genome Project and was categorized into 
the FAM83 gene family based upon sequence similarity. It is predicted to have 5 exons with a 
non-coding Exon 1 and a large Exon 5, and to encode a protein of 1179 amino acids with a 
calculated molecular mass of 127-kDa (Kim et al., 2008). Domain analysis of FAM83H protein 
reveals neither a signal peptide nor any known functional domains except an N-terminal 
phospholipase D-like (PLD-like) domain (amino acids 17-281), which is the shared element 
among all the members in FAM83 family and gives the group its identity. However, the trace 
homology between this domain and PLD suggests the unlikeliness of FAM83H having PLD-like 
enzyme activity, and leaves the functions of this protein still unknown (Kim et al., 2008; Ding et 
al., 2009). 
At least 20 different disease-causing FAM83H mutations have been so far identified (Fig. 
1.4) (Wang et al., 2013). All the mutations are either nonsense mutations (17/20) or frameshifts 
(3/20) located at 5’ region of Exon 5. Introducing premature stop codons at the last exon, all 
reported mutations are predicted to produce mutant transcripts that can escape nonsense 
mediated decay and are expected to generate truncated proteins lacking the normal C-terminus 
(from p.287Ser* to p.Glu694*). There are no other types of loss-of-function mutations reported, 




Figure 1.4: FAM83H disease-causing mutations. 
FAM83H gene structure: numbered boxes indicate exons; introns are lines connecting the exons. The 
numbers above each intron indicate the length of the intron in basepairs (bp). The numbers below each 
exon show the length of the exon in bp and below that the range of amino acids encoded by it. Shaded 
exon regions are non-coding. The 21 FAM83H missense or frameshift mutations are located between the 
sites marked 1 and 21 in bold. The gene numbers start from the first nucleotide of the FAM83H reference 
sequence NG_016652.1. The cDNA numbers start from the translation initiation site of FAM83H 
reference sequence NM_198488.3. This image is reproduced and modified from Appendix Figure 5 of 
reference (Wang SK, Hu Y, Simmer JP, Seymen F, Estrella NM, Pal S, Reid BM, Yildirim M, Bayram 
M, Bartlett JD, Hu JC (2013). Novel KLK4 and MMP20 mutations discovered by whole-exome 




mutations have even been reported more than once from different ADHCAI kindreds, suggesting 
a high genetic homogeneity of FAM83H disease-causing mutations (Fig. 1.4) (Wang et al., 
2013). 
 The general goal of the studies incorporated into this thesis was to identify critical players 
of tooth formation and to understand their roles and functions during this developmental process. 
Our main approaches were to conduct mutational analyses in families with familial tooth 
agenesis and amelogenesis imperfecta and to characterize FAM83H protein at molecular level. 
These genetic and biochemical approaches were used to find new players in tooth and enamel 
formation and gather information to unravel the roles of FAM83H in normal development as 
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MUTATIONAL ANALYSIS – FAMILIAL TOOTH AGENESIS 
 
ABSTRACT 
Tooth agenesis is the most prevalent craniofacial congenital anomaly in humans. The 
term refers to an isolated disorder in the absence of non-dental phenotypes but is also used to 
describe the manifestation of missing teeth in syndromes. The affected individuals suffer from 
compromised masticatory functions and have decreased quality of life. Discerning the genetic 
etiology of tooth agenesis not only improves our understanding of normal tooth development but 
also provides a fundamental basis for developing potential therapeutic strategies for this 
anomaly. To date, MSX1, PAX9, AXIN2, EDA, and WNT10A have been established as candidate 
genes associated with non-syndromic tooth agenesis. However, there are still many cases for 
which the genetic mutations cannot be found in these genes, suggesting high genetic 
heterogeneity of this disorder. In this thesis, we described 7 families with non-syndromic tooth 
agenesis, in which there was considerable variation in the number and class of teeth that were 
involved, and aimed to define the causative mutations for the disease. We identified a novel 
PAX9 mutation (c.43T>A, p.Phe15Ile) in a family of which the proband had 10 missing teeth and 
two reported WNT10A mutations (c.321C>A, p.Cys107*; c.682T>A, p.Phe228Ile) in another 
family of which two compound heterozygous individuals had 8 and 15 teeth missing. However, 
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for the other 5 families, we were still unable to define their genetic defects even with the exome 
sequencing analyses. Our results reaffirmed the genotypic and phenotypic heterogeneity of tooth 
agenesis. In the future, we need to recruit more families with similar phenotypes and collectively 
analyze their exome data at a “genetic pathway level,” meaning that mutations in genes involved 
in similar pathways should be considered to probably cause similar disease phenotypes. For 
sporadic cases, the genetic cause should not be determined until the whole exome data has been 
scrutinized, especially for those who have mild phenotypes (missing only one or two teeth), since 
genotype-phenotype segregation cannot be discerned to confirm the causality in these cases. 
 
INTRODUCTION 
In vertebrates, tooth development starts when specific epithelial domains of the first 
branchial arch express inductive signals to underlying mesenchyme, which defines the 
“odontogenic fields” that determine the location of future teeth. Subsequently, the odontogenic 
potential shifts to the mesenchyme, and mesenchymal factors signal back to epithelium and 
direct tooth bud morphogenesis (Tucker and Sharpe, 2004; Nanci, 2008; Thesleff, 2013). 
Disturbances during this early process of tooth development will lead to developmental arrest of 
tooth buds and cause tooth agenesis (De Coster et al., 2009; Parkin et al., 2009). 
Tooth agenesis is the most prevalent craniofacial congenital anomaly in humans. More 
than 20% of people fail to develop at least one of the third molars (wisdom teeth) and 3–10% one 
or more of the other permanent teeth (Parkin et al., 2009; Nieminen, 2009). There is considerable 
variation in the number and class of teeth that can be involved. Except third molars, the lower 
second premolars are the most commonly affected, followed by upper lateral incisors and upper 
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second premolars in Caucasian populations (Nieminen, 2009; Cobourne and Sharpe, 2013). 
Different terms have been used to describe the severity of tooth agenesis. While “hypodontia” 
refers to the situation with less than six missing teeth, “oligodontia” is used to indicate a more 
severe condition with six or more missing teeth except third molars (Nieminen, 2009). 
Tooth agenesis is usually an isolated abnormality, but it can also be one of the 
manifestations of syndromes, such as ectodermal dysplasia (Cobourne and Sharpe, 2013). 
Especially, a significant proportion of severe tooth agenesis happens in syndromes, in which the 
affected individuals suffer from compromised masticatory functions and decreased quality of 
life. Unraveling the genetic etiology of tooth agenesis not only gains our understanding of 
normal tooth development but also provides a fundamental basis for developing potential 
therapeutic strategies for this anomaly. To date, mutations in MSX1 (Msh homeobox 1), PAX9 
(paired box 9), AXIN2 (axis inhibition protein 2), EDA (ectodysplasin A), and WNT10A 
(Wingless-type MMTV integration site family, member 10A) have been identified to cause non-
syndromic tooth agenesis (Vastardis et al., 1996; Stockton et al., 2000; Tao et al., 2006; Bohring 
et al., 2009), which suggested the significant functions of these genes in early tooth 
development. However, there is still a remarkable portion of tooth agenesis cases for which the 
disease-causing mutations cannot be identified in these candidate genes, highlighting the great 
genetic heterogeneity of this congenital disorder (Bergendal et al., 2011; Arte et al., 2013). 
Our group has been working on mutational analysis of human inherited dental defects for 
decades, and Dr. Jan Hu has been actively recruiting families with these disorders. In this chapter 
of the thesis, we described families and sporadic individuals with tooth agenesis that we have 
conducted mutational analyses on to determine the genetic etiology of the disorder. We applied a 
target gene approach with known candidate genes for non-syndromic tooth agenesis as well as 
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whole exome sequencing when disease-causing mutations could not be identified in those genes. 
Through this research, we aimed for not only expanding the mutational spectrum of known 




Family 1 and a PAX9 mutation 
The proband was an 8-year-old boy with a total of 10 missing teeth (tooth numbers 2, 5, 
12, 13, 15, 18, 24, 25, 29, 31) excluding the third molars for which missing status could not be 
determined due to his young age (Fig. 2.1). The disease trait of tooth agenesis was inherited from 
his mother, who had 4 missing teeth (tooth numbers 4, 13, 24, 25) in addition to 4 missing third 
molars, suggesting a dominant pattern of inheritance. Using a target gene approach, we identified 
a heterozygous missense mutation (c.43T>A, p.Phe15Ile) in PAX9 in the proband and his 
mother, but not the unaffected father. This mutation substituted a highly-conserved amino acid 
phenylalanine15 with isoleucine in the paired box domain critical for DNA-binding ability of 
PAX9. Therefore, we concluded that this PAX9 mutation causes the tooth agenesis phenotype in 
this family. The result of this work has been published (Wang et al., 2012). 
 
Family 2 and WNT10A mutations 
Family 2 was a 4-generation Caucasian family with familial tooth agenesis (Fig. 2.2). The 




Figure 2.1: Family 1 pedigree, missing teeth, and disease causing mutations. 
A: The family pedigree follows the tooth agenesis trait for 3 generations and is consistent with an 
autosomal-dominant pattern of inheritance. Key: A filled icon indicates tooth agenesis. A dot indicates 
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individual who donated samples. B: Chart of missing teeth in mother (II:5) and the proband 
(III:1). C: DNA sequencing chromatograms show that the affected mother (II:5) and proband (III:1) had a 
T or A (W) (arrowhead) at position g.5368 (NCBI Ref. Seq. NC_000014.8). This PAX9 mutation 
(g.5368T>A; c.43T>A; p.Phe15Ile) caused the tooth agenesis. D: DNA sequencing chromatograms show 
both parents (II:5; II:6) had the wild-type G, while the proband had a G or A (R) (arrowhead) at position 
g.15941 (NCBI Ref. Seq. NG_007405.1). This spontaneous COL1A2 mutation (g.15941G>A; 
c.1171G>A; p.Gly391Ser) caused the dentin defects in the proband. E: Radiographs of the mother (II:5) 
and proband (III:1) document the missing teeth (arrowheads) and the peg lateral (*) in the proband. Oral 
photos show the proband’s primary anterior teeth show the brownish discoloration and attrition. His 
maxillary incisors were removed because of severe attrition and a pediatric partial denture was placed. 
The proband’s radiographs show the bulbous crowns with cervical constrictions and thin, narrow roots. 
This image is reproduced from Figure 1 of reference (Wang SK, Chan HC, Makovey I, Simmer JP, Hu JC 
(2012). Novel PAX9 and COL1A2 missense mutations causing tooth agenesis and OI/DGI without 
skeletal abnormalities. PLoS One 7:e51533.). 
 
excluding third molars. Her older sister (III:2) was also affected with 2 missing lower second 
bicuspids. While her husband (III:4) was unaffected and had full set of permanent teeth, two of 
her three children were missing multiple teeth. The first child (IV:3) had all permanent teeth 
except 2 missing upper third molars. The second child (IV:4) was a 10-year-old boy who had 8 
missing teeth (tooth numbers 2, 4, 13, 15, 18, 24, 25, 31) and 2 peg lateral incisors (small teeth), 
and the third child, a 7-year-old girl (IV:5), had a total of 15 missing teeth (tooth numbers 2, 4, 7, 
10, 12, 13, 15, 18, 20, 23, 24, 25, 26, 29, 31). The pedigree analysis suggested a dominant pattern 
of disease inheritance and a variation in disease expressivity between generations. In addition to 
dental phenotype, no other developmental anomalies were observed, except that the mother 
claimed that the hair growth of her two younger children was slow. 
For mutational analysis, we first used a target gene approach but failed to find any 
potential disease-causing mutations in MSX1, PAX9, AXIN2, or EDA, the 4 candidate genes 
known to cause non-syndromic tooth agenesis at that time. Assuming that the genetic defect 
might be in a novel gene, we then submitted DNA samples from 4 of the family members (III:2, 




Figure 2.2: Family 2 pedigree, missing teeth, and disease causing mutations. 
A: The family pedigree exhibits an autosomal-dominant pattern of inheritance. A filled icon indicates 
tooth agenesis. A question mark indicates undetermined disease phenotype. A slash indicates deceased 
individual. A dot indicates individual who donated samples. B: Chart of missing teeth in all 
participants. X: missing tooth; P*: peg lateral; ?: undetermined status. C: DNA sequencing 
chromatograms show the nonsense WNT10A mutation (g.6836C>A, c.321C>A, p.Cys107*) and the 
missense WNT10A mutation (g.14757T>A, c.682T>A, p.Phe228Ile). The mutation designations are with 
respect to the WNT10A genomic reference sequence NG_012179.1 and cDNA reference sequence 
NM_025216.2. W means C or A. R means T or A. 
 
genome-wide search. However, at the same time, a report showed that people carrying a 
heterozygous loss-of-function mutation of WNT10A, a gene responsible for a specific type of 
ectodermal dysplasia when both alleles are defected, had missing teeth, which suggested 
WNT10A as a novel candidate gene for tooth agenesis (Bohring et al., 2009). Therefore, we 
included WNT10A in our analysis and found two WNT10A mutations (g.6836C>A, c.321C>A, 
p.Cys107* and g.14757T>A, c.682T>A, p.Phe228Ile) running in this family (Fig. 2.2). While the 
proband (III:3) and her sister (III:2) were heterozygotes for the nonsense mutation (c.321C>A, 
p.Cys107*), both of the two affected children (IV:4, IV:5) were compound heterozygotes for 
these two mutations (c.321C>A, p.Cys107* and c.682T>A, p.Phe228Ile). More interestingly, the 
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unaffected father and the first child (III:4, IV:3) carried the missense mutation (c.682T>A, 
p.Phe228Ile) and the nonsense mutation (c.321C>A, p.Cys107*) respectively. These two 
WNT10A mutations have been reported to cause odonto-onycho-dermal dysplasia (OODD), a 
rare autosomal-recessive inherited form of ectodermal dysplasia, in a homozygous condition 
(Bohring et al., 2009). Therefore, the diagnosis of the two affected children, who had more 
severe tooth agenesis phenotype, should be revised from non-syndromic to syndromic tooth 




Family 3 is a 4-generation Caucasian family with 6 affected individuals of tooth agenesis 
(including a pair of identical twins) out of total 22 recruited family members (Fig.2.3). The 
pattern of missing teeth in the family was of missing only premolars. The proband (III:11) was a 
17-year-old girl who had three missing premolars (tooth numbers 4, 20, 29), and her younger 
sister (III:12) missed all of her permanent premolars (tooth numbers 4, 5, 12, 13, 20, 21, 28, 29) 
but had a mesiodens (a supernumerary tooth between upper central incisors). The father (II:8) 
had three missing teeth (tooth numbers 4, 20, 29), while his twin brother (II:7) had four (tooth 
numbers 4, 13, 20, 29). The two affected aunts (II:3, II:4) had tooth numbers 20, 29 and tooth 
number 4 absent respectively. According to the mother (II:9), the hairs of her affected husband 
and two daughters were thin, but there was no problem of heat intolerance. The distribution of 
phenotypes in family members suggested the tooth agenesis was inherited in a dominant manner; 
however, there might be penetrance issue of disease phenotype since only 2 out of 11 potentially-
affected offspring in the 3rd generation showed tooth agenesis (Fig. 2.3). 
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Figure 2.3: Family 3 pedigree 
and missing teeth. 
A: The family pedigree exhibits an 
autosomal-dominant pattern of 
inheritance with probable incomplete 
penetrance of disease phenotype. 
Individuals II:7 and II:8 are identical 
twins. A filled icon indicates tooth 
agenesis. A slash indicates deceased 
individual. A dot indicates individual 
who donated samples. B: Chart of 
missing teeth in all affected 
individuals. The involved teeth are 
premolars and third molars. An X 
indicates a missing tooth. Individual 
III:12 has a mesiodens between upper 






The pattern of missing teeth in the family (only premolars and third molars) made MSX1 
the most likely candidate gene responsible for the disorder, based upon previous reports of MSX1 
mutations (Vastardis et al., 1996; Kim et al., 2006). However, we failed to identify any potential 
disease-causing mutations in MSX1 or PAX9. We then sequenced the whole exomes of 8 family 
members, 4 affected (II:3, II:4, III:11, III:12) and 4 unaffected (II:9, II:11, III:8, III:10), and 
selected potential disease-causing sequence variations by analyzing and comparing exome 
sequencing data from different individuals. The analyzed exome sequencing data and the gene 
lists of non-reference sequence variants after comparison were provided by Dr. Manjusha Pande 
at the University of Michigan Bioinformatics Core. 
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Combining the exome data from all the 8 individuals, there were total 3,148 sequence 
variants different from human reference sequence with a less than 5% minor allele frequency 
(MAF) in general populations. Among these, there were 487 variants shared by at least 3 
affected individuals but no more than 2 unaffected individuals, and there were only 8 variants 
shared by all the affected but none of the unaffected individuals (Tab. 2.1). They were sequence 
variants in MFSD9, MUC4, KIAA1109, HOXC6, SLC39A5, MYO1A, CDC27, and MUC16. 
Unfortunately, at this stage, we were not able to confidently define the actual disease-causing 
mutations from these candidate sequence variants. 
 
Table 2.1: Sequence variants from exome analysis of Family 3. 
Whole exomes of 4 affected (II:3, II:4, III:11, III:12) and 4 unaffected (II:9, II:11, III:8, III:10) 
individuals were analyzed comparatively. A total of 3,148 sequence variants different from human 
reference sequence with a less than 5% minor allele frequency (MAF) in general populations was 
obtained. The listed 8 sequence variants are the ones shared by all the affected but none of the unaffected 
individuals. This table is derived from a gene list of exome analysis (Oligodontia_variants_3148.xlsx) 















Chr2 103340233 C A MFSD9 p.G188V missense Damaging 55839709 
Chr3 195506306 G C MUC4 p.L4049V missense   
Chr4 123108639 T C KIAA1109 p.I200T missense Damaging  
Chr12 54422504 C T HOXC6 p.R67W missense Damaging 144307645 
Chr12 56630985 T C SLC39A5 p.L447P missense Damaging 76216511 
Chr12 57441459 G A MYO1A p.R93* stop gain  121909305 
Chr17 45249316 T C CDC27 p.Y73C missense Tolerated 62077266 





Family 4 was a 5-generation Caucasian family of which the male proband (V:1) had only 
one missing tooth of lower right second premolar (Fig. 2.4). His younger brother (V:2) was 
unaffected, and the youngest brother (V:3) is too young to determine his dental status. However, 
the father (IV:4) was more severely affected with missing 4 premolars and one molar (tooth 
numbers 5, 13, 20, 29, 31). The uncle (IV:5) was reported to have 6 missing teeth, and his two 
children (V:4, V:5) were missing tooth number 4 and 29 respectively, but they were not 
successfully recruited to the study. Noticeably, although there were 4 affected individuals on the 
other side of the family, the phenotype is different from that of the proband’s side. Instead of 
missing premolars, the individuals III:7, IV:12, V:8, and V:9 were reported to have anterior teeth 
missing (lateral incisors and canines) (Fig. 2.4). 
We submitted 6 DNA samples, including 4 affected (III:4, V:1, III:7, V:8) and 2 
unaffected (IV:7, III:5) individuals, for whole exome sequencing. The variation in the disease 
 Figure 2.4: Family 4 pedigree 
and missing teeth. 
A: The family pedigree exhibits an 
autosomal-dominant pattern of 
inheritance. A filled icon indicates 
tooth agenesis. A question mark 
indicates undetermined disease 
phenotype. A slash indicates deceased 
individual. A dot indicates individual 
who donated samples. B: Chart of 
missing teeth in affected individuals 
whose radiographs can be obtained 
and missing teeth confirmed. X: 





phenotypes made us suspect that there might be two phenotypic traits and causative mutations 
running in this family. Based upon this assumption, we analyzed the data from each side of the 
family separately and listed all the sequence variants sorted by different criteria. The analyzed 
exome sequencing data and the gene lists of non-reference sequence variants after comparison 
were provided by Dr. Murim Choi. 
On the proband’s side (trait of premolar missing), there were 19 sequence variants shared 
by the two affected individuals (III:4, V:1). Eight of these variants were not present in the 
unaffected member (IV:7) (Tab. 2.2), and are each potentially responsible for the trait of missing 
premolars. On the other side of the family (trait of anterior teeth missing), only 7 sequence 
variants were shared by two affected individuals (III:7, V:8), but all of them were also present in 
the unaffected member (III:5). Although several sequence variants appeared to be potentially 
disease-causing, none of them showed strong biological relevancy to tooth development. 
Therefore, we were unable to confidently define the actual disease-causing mutations from these 
candidate sequence variants. 
 
Family 5, 6, and 7 
The probands of Family 5, 6, and 7 all showed severe form of oligodontia in which 
multiple anterior and posterior teeth were involved. It is possible that the disease phenotypes of 
these families share the same genetic etiology. Also, considering the relatively small size of these 
families, we grouped them together for mutational analysis. 
The proband of Family 5 (III:2) was the only family member whose dental record was 
available and phenotype confirmed. She had a total of 15 missing teeth (tooth numbers 4, 5, 6, 7, 
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Table 2.2: Sequence variants from exome analysis of Family 4. 
Whole exomes of 2 affected (III:4, V:1) and 1 unaffected (IV:7) individuals from the left side of Family 4 
pedigree (cases of premolar missing) were analyzed comparatively. The listed 8 sequence variants are the 
ones shared by the two affected but not the unaffected family members. This table is derived from gene 




Het/Hom Gene Status AA change PhyloP SIFT Polyphen2 
chr11 33612954 G>A Het C11orf41 Missense E1283K 5.716 0.17 0.999 
chr5 118511024 T>A Het DMXL1 Missense H2250Q 0.613 0.18 0.051 
chr3 52380742 +GG Het DNAH1 Indel T637 -2.185   
chr14 102568306 A>G Het HSP90AA1 Missense F91S -1.204 0 0.023 
chr16 75675599 C>G Het KARS Missense A29P 5.982 0.1 1.0 
chr5 115831951 T>C Het SEMA6A Missense H113R 4.888 0.02 0.524 
chr5 171520934 +AGA Het STK10 Indel E346 1.583   
chr3 44685396 C>G Het ZNF197 missense T925S 1.761 0.08 0.976 
 
10, 11, 12, 20, 21, 23, 24, 25, 26, 28, 29) (Fig. 2.5). Both her parents were reported to have 
“good teeth,” but the actual dental phenotypes could not be confirmed. Since the mode of disease 
inheritance could not be determined, we considered the proband as a sporadic case when 
conducting mutational analysis, meaning all the heterozygous and homozygous sequence 
variants were evaluated. 
The proband of Family 6 (III:2) was a boy who had 12 missing teeth (tooth numbers 2, 7, 
10, 15, 18, 20, 23, 24, 25, 26, 29, 31) (Fig. 2.5). The disease phenotype seemed to be inherited 
from the paternal side, since his father was reported to have 6 missing teeth, and two other 
siblings of the father were also reported to be affected. However, only the proband, his sister, and 




Figure 2.5: Pedigrees and missing teeth of Family 5, 6, and 7. 
A: The Family 5 pedigree shows that the proband may be a sporadic case of tooth agenesis. The Family 6 
and 7 pedigrees exhibit an autosomal-dominant pattern of inheritance. A filled icon indicates tooth 
agenesis. A question mark indicates undetermined disease phenotype. A dot indicates individual who 
donated samples. All members of Family 7 donated samples. B: Charts of missing teeth in the probands 
of Family 5 and 6, and affected individuals of Family 7. All patients are severe cases of oligodontia. 
While the proband of Family 5 has a total of 15 missing teeth, the proband of Family 6 is missing 12 
teeth. In Family 7, the individuals I:2, II:1, II:2, and II:3 are missing 11, 11, 9, and 18 teeth respectively. 
Interestingly, although multiple teeth are involved, second molars are all present. An X indicates a 
missing tooth. 
 
Family 7 was a small family of 5 members with 4 of them having severe tooth agenesis 
(Fig. 2.5). The proband (II:3) had a total of 18 missing permanent teeth (tooth numbers 4, 5, 6, 7, 
10, 11, 12, 13, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29) with multiple over-retained primary teeth. 
His older sister (II:1) and brother (II:2) were also affected with missing 11 (tooth numbers 5, 6, 
7, 10, 11, 12, 23, 24, 25, 26, 28) and 9 (tooth numbers 4, 6, 7, 10, 11, 13, 23, 26, 28) permanent 
teeth respectively. The disease trait seemed inherited from the mother (I:2), since she was 
missing 11 teeth (tooth numbers 4, 5, 12, 13, 19, 20, 21, 22, 27, 28, 29). Despite that the 
“unaffected” father (I:1) also had one missing tooth of upper left lateral incisor, the disease 
phenotype showed a dominant pattern of inheritance. Although the condition of tooth agenesis in 
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this family was significant, no abnormalities other than dental phenotype from any individual 
were reported. 
For mutational analysis, we first searched for mutations in candidate genes, including 
MSX1, PAX9, AXIN2, EDA, WNT10A, BMP4, OSR2, and HOXC6, but no potential disease-
causing sequence variations were observed in probands of all three families. We then sequenced 
and analyzed the exomes from the three probands, listed all the sequence variants for each 
individual, and inspected them individually. The analyzed exome sequencing data and the gene 
lists of non-reference sequence variants after comparison were provided by Dr. Murim Choi. 
Also, under the assumption that there might be two probands sharing the same genetic etiology, 
we then compared the sequence variants between any two out of the three exomes, and sorted out 
the candidate genes in which both exomes had sequence variants (Tab. 2.3). However, none of 
the approaches gave us strong candidates, so at this stage we were unable to confidently define 
the actual disease-causing mutation for any of the three families. 
 
Table 2.3: Gene lists from exome comparison of Family 5, 6, and 7 probands. 
Any 2 out of 3 exomes from different probands were compared. The listed genes are the ones in which the 
compared two exomes have non-reference sequence variants. Genes marked with red are genes in which 
all three probands have non-reference sequence variants. This table is derived from gene lists of exome 
analyses (NOVELVAR_n29.xlsx) provided by Dr. Murim Choi. 
Compared probands Genes in common 
Family 5, Family 6 CD24, CFTR, MUC4, PCNXL2, PRSS1, SGK1, SLC25A5 
Family 5, Family 7 
C8orf73, CD24, CFTR, MUC4, PABPC1, PRSS1, SLC25A5, 
UHRF1, VPS36 
Family 6, Family 7 





WNT10A mutations and non-syndromic tooth agenesis 
Human WNT10A mutations, in a homozygous condition, were first identified to cause 
Odontoonychodermal dysplasia (OODD; MIM#257980), a rare autosomal recessive syndrome 
characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform 
and filiform papillae, onychodysplasia, keratoderma, and hyperhidrosis (Adaimy et al., 2007). 
With significant variation in disease severity, a brother and sister from one of the reported 
families had oligodontia and sparse body hair and eyebrows as their only manifestations. 
Interestingly, a subsequent study of WNT10A mutations reported that about half of the 
heterozygous carriers in OODD families showed a phenotype manifestation, including mainly 
tooth and nail anomalies (Bohring et al., 2009), suggesting that tooth agenesis in patients without 
other abnormalities might result from a heterozygous WNT10A mutation. 
With WNT10A being established as a candidate gene for non-syndromic tooth agenesis, 
we identified 2 reported WNT10A mutations (c.321C>A, p.Cys107*; c.682T>A, p.Phe228Ile) in 
a 3-generation Caucasian family (Family 2). Two affected children were compound 
heterozygotes for both mutations, although they didn’t show apparent OODD abnormalities other 
than severe oligodontia, which made us revise the disease diagnosis. The mother and the aunt, 
who had 1 and 2 premolars missing respectively, were heterozygous carriers of the nonsense 
mutation (p.Cys107*), which explained their milder disease phenotypes, compared to those of 
the two affected children. However, interestingly, the unaffected father, who had full set of 
permanent teeth, and older sister, who had only two third molars missing, were carriers for the 
p.Phe228Ile and p.Cys107* mutations respectively, suggesting an incomplete penetrance of the 
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phenotype with heterozygous mutant WNT10A alleles. Genotypically, the disease in this family 
should be considered “autosomal recessive,” although it appeared to be “autosomal dominant” 
phenotypically, which well explained the more severe disease phenotype in children’s 
generation. The incomplete penetrance of disease phenotype from a mild mutant allele (WNT10A 
p.Phe228Ile in this case) sometimes can be misleading. Therefore, among the candidate genes of 
non-syndromic tooth agenesis, WNT10A might be the one in higher priority, when people are 
searching for genetic defects in families with variable disease severity between generations. 
It has been well recognized that Wnt/β-catenin signaling is critical for tooth development. 
While ablation of Wnt/β-catenin signaling in mice causes tooth developmental arrest at early 
stage, constitutive activation of β-catenin leads to formation of supernumerary teeth (Sasaki et 
al., 2005; Liu et al., 2008). The discovery that WNT10A mutations are associated with human 
tooth agenesis reaffirmed the significance of Wnt signaling pathway in early tooth development. 
Recently, many different WNT10A mutations were reported to cause non-syndromic tooth 
agenesis with remarkable variation in disease severity, and it has even been reported that 
mutations in WNT10A are present in more than half of isolated hypodontia cases based on study 
of 58 Caucasian subjects (van den Boogaard et al., 2012; Song et al., 2014). However, in many 
cases, the researchers performed target gene approaches with selected candidate genes and 
arbitrarily assigned the disease-causing mutations without confirming disease segregation, 
especially for sporadic cases, which makes the genetic causality suspicious. For example, some 
have reported that individuals with a heterozygous WNT10A p.Phe228Ile mutation have more 
than 10 missing teeth, with the maximum of 18 in the literature (van den Boogaard et al., 2012), 
while others, including us, found that this specific mutation causes mild tooth agenesis or 
sometimes no missing teeth. Nevertheless, it is unlikely that a sequence variant can cause such a 
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wide spectrum of disease severity from no phenotype to severe phenotype, suggesting that the 
reported variant might not be the actual genetic defect responsible for the disorder. People may 
argue that there might be some genetic modifiers that affect the phenotypic expressivity of this 
variant. However, before these genetic modifiers are actually identified and confirmed, one 
needs to be cautious about determining disease-causing mutations in the cases whose phenotypes 
are much more extreme than those of reported cases. Therefore, additional investigations need to 
be conducted before one can conclude that WNT10A mutations are the major genetic cause of 
non-syndromic tooth agenesis (van den Boogaard et al., 2012; Song et al., 2014). 
 
Variable genetic penetrance and expressivity in familial tooth agenesis 
In our Family 3, the family pedigree indicated a dominant manner of disease inheritance. 
However, among total 16 individuals who had 50% chance to be affected, there were only 4 
actually showed the disease phenotype (Fig. 2.3). This disobedience to Mendelian proportion for 
dominant inheritance highly suggested an incomplete phenotypic penetrance of the genetic 
defect in this family. This lack of penetrance is commonly seen in many of the human genetic 
diseases, including familial tooth agenesis, which makes it more difficult to identify the genetic 
etiology in some families. In the case of Family 3, the family size was relatively large, which 
theoretically increased the genetic power to identify the disease-causing mutation. However, the 
incomplete penetrance offset this advantage. Although we analyzed the exomes from 8 family 
members and selected certain candidate sequence variants, we were still not able to determine 
the genetic etiology, especially when little was known about the functional impacts of those 
variants. Therefore, in order to confidently define the disease-causing mutation in Family 3, we 
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might need more families with similar phenotypes and probably defects in the same causative 
gene to support the genetic causality. 
Another interesting characteristic of familial tooth agenesis is the variable phenotypic 
expressivity (disease severity) within the family. Sometimes the variation could be very 
significant between individuals carrying the same genetic defect. For example, in Family 1, 
despite that the proband and his mother had the same PAX9 p.Phe15Ile mutation, the mother had 
only 4 missing teeth, while the prohand had 10. In Genetics, this phenomenon has been 
explained by a hypothetical existence of “genetic modifiers,” meaning that some unidentified 
genetic functional elements might affect or “modify” the observed phenotypes. Nevertheless, in 
spite of the underlying mechanism, the variation in expressivity sometimes could be misleading 
in mutational analysis. For instance, in Family 2, based upon disease phenotype, there seemed to 
be a significant expressivity variation between generation III and IV. However, the different 
disease severity actually resulted from carrying one or two defective alleles. Therefore, in such 
cases, carefully characterizing the disease phenotype and confirming the segregation between 
genotype and phenotype are particularly important to determine the genetic causality. 
 
Phenotypic and genotypic heterogeneity in familial tooth agenesis 
It has been observed that the pattern of missing teeth in familial tooth agenesis is, to some 
extent, associated with its genetic etiology. While second bicuspids and third molars are 
frequently involved in MSX1-associated tooth agenesis, PAX9 mutations usually lead to tooth 
agenesis of second bicuspids, second molars, third molars, and some central incisors (Kim et al., 
2006). People with EDA mutations tend to have multiple anterior teeth missing but first molar 
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preserved (Han et al., 2008). In AXIN2-associated tooth agenesis, the affected individuals usually 
have severe oligodontia, with multiple anterior and posterior teeth missing (Lammi et al., 2004). 
Moreover, it was recently reported that WNT10A mutations cause tooth agenesis with lateral 
incisors and second premolars being frequently involved (Kantaputra and Sripathomsawat, 2011; 
Song et al., 2014), although some reported that there is no specific pattern of missing teeth in 
WNT10A-associated tooth agenesis (Plaisancié et al., 2013; van den Boogaard et al., 2012). This 
genotype-phenotype correlation is sometimes very useful for prioritizing the candidate genes in 
mutational analysis. For example, in our Family 1, the proband had a typical pattern of missing 
teeth associated with PAX9 mutations, and we eventually identified the PAX9 p.Phe15Ile 
mutation responsible for the disease. However, the phenotype is not always predictive for the 
genetic etiology, and given the potential for oligogenic effects, the mutational analyses may 
provide an incomplete picture of the genetic etiology. In Family 3, the pattern of missing teeth in 
affected individuals (missing of premolars and third molars) suggested MSX1 might be the 
responsible gene, but we failed to find any potential disease-causing mutation in MSX1. 
However, this inconsistency suggested that the actual gene involved in the disease of this family 
might function in the related genetic pathway with MSX1, so when the gene is defected, the 
affected individual shows similar phenotype to that of MSX1-associated tooth agenesis. In this 
sense, families with similar phenotypes but different genetic causes may provide a valuable in 
vivo tool to study genetic pathways and gene-gene interactions. However, it is also possible that 
the mutation is at the regulatory region of the gene, which cannot be easily determined. 
As mentioned previously, although mutations in MSX1, PAX9, AXIN2, EDA, and 
WNT10A have been shown to cause non-syndromic tooth agenesis, there are still many cases of 
which the genetic mutations cannot be found in these candidate genes, indicating high genetic 
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heterogeneity of this disorder (Bergendal et al., 2011; Arte et al., 2013). In this thesis, the genetic 
etiology of tooth agenesis in 5 out of 7 families still needs to be determined.  Recently, whole 
exome sequencing has been demonstrated to be a powerful tool in human mutational analysis 
(Bamshad et al., 2011; Goh and Choi, 2012). In many cases, by combining the data from 
unrelated affected individuals with the same disease, the genetic power is significantly increased, 
and the responsible gene is readily identified (Rabbani et al., 2012). However, for diseases with 
high genetic heterogeneity, this approach may not work, since similar phenotypes can result from 
distinct genetic causes. We combined and analyzed the exome data from the probands of Family 
5, 6, and 7, but still failed to identify the causative mutation in any of the families. Sometimes, a 
larger family size can help to overcome the problem from genetic heterogeneity of the disease. 
With more affected and unaffected family members, the genetic linkage may provide significant 
power to locate the disease locus in the genome and help to identify the mutation (Bailey-Wilson 
and Wilson, 2011). For example, linkage analyses of two large families with tooth agenesis have 
mapped new disease locus to chromosome 16q12.1 and 10q11.2, although no candidate genes 
have yet been identified at these loci (Ahmad et al., 1998; Liu et al., 2001). Unfortunately, the 
sizes of most of the families we described here were relatively small, which makes linkage 
analysis impossible. Therefore, in order to actually identify the responsible genes in these 
families with unknown genetic defects, we may need supportive evidence from mouse models, 
linkage data of other large families, or more individual cases with similar disease phenotypes. 
 
Prospects in mutational analysis of familial tooth agenesis 
Discerning the genetic etiology of human tooth agenesis significantly gain our 
understanding of tooth development. All the candidate genes identified so far and their roles in 
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tooth formation have been extensively studied (Nieminen, 2009). However, as discussed above, 
due to the genotypic and phenotypic heterogeneity of the disease, the genetic etiology of a 
significant number of cases still waits to be determined. In the future, for large-sized families, we 
should take advantage of the genetic linkage power to define disease locus and further analyze 
with exome sequencing data to pinpoint the disease-causing mutation (Bailey-Wilson and 
Wilson, 2011; Wijsman, 2012). For relatively small-sized families, we need to recruit multiple 
families with similar phenotypes and collectively analyze their exome data at a “genetic pathway 
level,” meaning that mutations in genes involved in similar pathways need to be considered to 
probably cause similar disease phenotypes (Gilissen et al., 2012; Li et al., 2012). For sporadic 
cases, the genetic causes should not be determined until the whole exome data has been 
scrutinized, especially for those who have mild phenotypes (missing only one or two teeth), since 
genotype-phenotype segregation cannot be discerned to confirm the causality in these cases. 
Admittedly, the current mutational analysis focuses on the protein-coding region of the genome. 
However, one can fully appreciate that the genetic defects may locate at non-coding regulatory 
regions of the genome in certain cases. Therefore, whole genome sequencing may be the 
alternative approach to address this issue (Cooper and Shendure, 2011; Lyon and Wang, 2012). 
However, at this stage, we have very limited ability to interpret the functional impact of 
sequence variants found in regulatory regions. In other words, many efforts still need to be made 
to prove the utility of whole genome sequencing in human mutational analysis (Lyon and Wang, 
2012). 
Furthermore, since familial tooth agenesis is sometimes considered as a multifactorial 
genetic disease, people have tried to identify disease-associated loci through case-control studies 
with multiple candidate genes or genome wide association studies (GWAS) (Vieira et al., 2007; 
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Vieira et al., 2008; Haga et al., 2013; Liu et al., 2013). For example, an SNP, rs1469622, at an 
intron of THSD7B (thrombospondin, type I, domain containing 7B) was shown to be associated 
with third molar agenesis in Japanese and Korean populations (Haga et al., 2013). These 
association studies with large sample sizes can avoid some problems that traditional mutational 
analysis cannot conquer, such as genotypic and phenotypic heterogeneity of the disease, and may 
shed light on finding novel genes involved in tooth development. However, association studies 
only provide “genetic association,” the validation of disease causality still depends upon 
traditional mutational analysis and functional studies of specific genes. 
 
MATERIALS AND METHODS 
Family recruitment and ethics statement 
The human study protocol and subject consents were reviewed and approved by the 
Institutional Review Boards (IRB) at the University of Michigan and the University of Texas 
Health Science Center at San Antonio. Study participants signed appropriate written consents 
after an explanation of their contents and after their questions about the study were answered. 
Any minors age 8 or older signed a written assent form after their parent completed a written 
parental consent for participation of the minor. All the IRB processes were issued by Dr. Jan Hu. 
 
Phenotypic data collection and family pedigree construction 
During subject recruitment, we collected dental records, mainly radiographs, and took 
medical and dental history from each participant. When dental records were not available, 
determination of disease phenotype depended upon communication with the contact family 
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member, which compromised the validity of phenotyping. For each family, the genetic pedigree 
was then constructed based up the phenotypic data. All the family recruitments, including 
collecting subjects’ samples and clinical data were conducted by Dr. Jan Hu. 
 
DNA extraction from blood and saliva samples 
Peripheral whole blood (5 cc) or saliva (2 cc) was obtained from recruited individuals of 
each family. Genomic DNA was isolated from blood or saliva with the QIAamp DNA Blood 
Maxi Kit (51194; Qiagen; Valencia, CA, U.S.A.) and the Saliva DNA Collection, Preservation 
and Isolation Kit (RU35700; Norgen Biotek Corporation; Thorold, Canada) respectively. The 
quality of the extracted DNA samples were determined by spectrophotometry at OD260 and 
OD280 and prepared for subsequent analyses. DNA extractions of blood/saliva samples from 
subjects described here were performed by Dr. Hui-Chen Chan, Rachel Milkovich, Soumya Pal, 
Bryan Reid, and myself. 
 
Mutational analysis (target gene approach) 
For each candidate gene of interest, the coding exons and intron junctions of the gene 
were amplified by polymerase chain reaction (PCR) with specific primer sets (Tab. 2.4). The 
amplification products were purified and characterized by direct DNA sequencing (Sanger 
sequencing) at the University of Michigan DNA Sequencing Core (Ann Arbor, MI, U.S.A.). The 
sequencing data was then examined by comparing it to the human reference sequence, and 
sequence variants called and evaluated. Target gene analyses for subjects described here were 
conducted by Rachel Milkovich, Soumya Pal, Bryan Reid, and myself. 
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Table 2.4: Primers and PCR conditions used for Sanger sequencing. 
Primer sets used for amplification of exons and exon-intron junctions of target genes (MSX1, PAX9, 
AXIN2, EDA, WNT10A, OSR2, BMP4, and HOXC6) are listed. For large exons, more than one primer set 
may be applied. 5% or 10% Dimethyl sulfoxide (DMSO) is used in PCR reactions with high GC-content 
amplicons. PCR amplifications were done using the Platinum® PCR Supermix (11306-016; InvitrogenTM 
by Life Technologies; Grand Island, NY, U.S.A.). The reactions had a 5 min denaturation at 94 ˚C, 
followed by 35 cycles each with denaturation at 94 ˚C for 30 sec, primer annealing at 56-58 ˚C for 60 sec, 
and product extension at 72 ˚C for 90 sec. In the final cycle the 72 ˚C extension was for 7 min. PCR 
amplification products were purified by QIAquick PCR Purification Kit and protocol (28106; Qiagen; 
Valencia, CA, U.S.A.). 
MSX1 





Ex1R GCCTGGGTTCTGGCTACTC Ex2R CAGGGAGCAAAGAGGTGAAA 
Annealing temperature (Ta): 58°C; *: 10% DMSO is required. 
PAX9 















Annealing temperature (Ta): 58°C 
AXIN2 






























Ex10R GTTCACCTGGTGGAAAGAGC Ex11R CACTGGCCGATTCTTCCTTA 
Annealing temperature (Ta): 57°C 
EDA 










Ex3R GGCTGGTTTTGAATTCCTCA Ex4R AAAAGAAGGGCAGGGAGAAG 
Ex5F TCACCCGAAGTCAGGAGTTT 826 Ex6F GGGTGCACTCTGACTCTTCC 333 
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Annealing temperature (Ta): 56°C; *: 5% DMSO is required. 
WNT10A 










Ex3R CGTGGTCCTCAGAAGAGAGG Ex4R CCTCTTCCCAAGAGCCAAG 
Annealing temperature (Ta): 57°C; *: 5% DMSO is required. 
OSR2 















Annealing temperature (Ta): 57°C; *: 5% DMSO is required. 
BMP4 















Annealing temperature (Ta): 57°C 
HOXC6 










Annealing temperature (Ta): 57°C 
 
Mutational analysis (whole exome sequencing) 
Whole exome sequencing was conducted at the University of Michigan DNA Sequencing 
Core (Ann Arbor, MI, U.S.A.) for Family 2 and 3 and Yale Center for Genome Analysis (West 
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Haven, CT, U.S.A.) for Family 4, 5, 6, and 7. At the University of Michigan DNA Sequencing 
Core, genomic DNAs (3μg) from subjects were assessed of their quality and quantity and 
subjected to whole exome sequencing, which was conducted by using Illumina TruSeq Exome 
Enrichmemt system and HiSeq 2000 platform at 75 base paired-end sequencing. Sequence 
output was inspected and aligned against human reference genome hg19, and variants were 
filtered and annotated using Ingenuity Variant Analysis tool by the University of Michigan 
Bioinformatics Core. At the Yale Center for Genome Analysis, the exome sequencing and 
subsequent analysis were modified from a previous report (Choi et al., 2009). Briefly, the 
genomic DNA was captured with NimbleGen v2.0 exome capture reagent (Roche/NimbleGen 
Incorporation; Madison, WI, U.S.A.) and sequenced with Illumina HiSeq 2000 for 75 base 
paired-end reads. Reads were aligned to human reference genome hg19 using ELAND v2. Single 
nucleotide variants and short insertions and deletions (indels) were called using SAMtools. The 
called variants were annotated using an in-house script. Next, the annotated results were first 
inspected to search for potential disease-causing sequence variations in the known candidate 
genes of syndromic and non-syndromic tooth agenesis. In families with multiple exomes being 
sequenced, the data from each were compared, and the sequence variations were further filtered 
based upon phenotype-genotype segregation. In some circumstances, exome data from unrelated 
affected individuals were compared and search for sequence variations of the same gene. Exome 
data analyses and generation of gene lists of non-reference sequence variants were conducted by 
Dr. Murim Choi. Eventually, potentially disease-causing sequence variations were confirmed in 
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MUTATIONAL ANALYSIS – AMELOGENESIS IMPERFECTA 
 
ABSTRACT 
Amelogenesis imperfecta (AI) is a collection of genetic disorders featured by 
developmental enamel defects. While isolated AI describes the enamel malformations in the 
absence of non-dental phenotypes, syndromic AI refers to the enamel defects manifested in 
syndromes. Patients afflicted with AI suffer from esthetic and functional burdens and have 
compromised quality of life. Discerning the genetic etiology of AI not only will improve our 
understanding of dental enamel formation but may also provide fundamental information that 
will impact therapeutic strategies for this anomaly. With decades of efforts, many genes have 
been identified to be associated with different types of AI and shown to play significant roles in 
different stages of amelogenesis. However, there is still a significant number of AI cases of 
which the genetic causes cannot be identified in these candidate genes. In this thesis, we 
described 12 AI kindreds and performed mutational analyses to identify the genetic etiology for 
their enamel defects. We successfully identified novel mutations in MMP20, KLK4, FAM83H, 
FAM20A, SLC24A4, and STIM1. Particularly, we demonstrated that mutations in FAM20A can 
cause Enamel-Renal Syndrome (ERS), in addition to Amelogenesis Imperfecta Gingival 
Fibromatosis Syndrome (AIGFS), and suggested that these two disorders may be the same 
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disease entity with variable presentation of renal calcifications. We also reported, for the first 
time, that human Integrin beta 6 (ITGB6) mutations cause generalized hypoplastic AI, which 
demonstrates that cell-matrix interaction and integrin signaling are critical for enamel formation. 
However, the failure to identify genetic defects in many AI families our lab recruited but not 
described in this thesis reaffirmed the high genetic heterogeneity of AI and revealed our current 
inadequate knowledge about enamel formation. In the future, we need to recruit more AI families 
with relatively similar phenotypes and collectively analyze their exome data using a “genetic 
pathway” approach to help identify AI candidate genes, meaning that mutations in genes 
involved in similar pathways need to be considered as potential causes resulting in similar 
disease phenotypes. Furthermore, mouse models with enamel defects can also predictively and 
supportively facilitate human AI mutational analysis using a reverse genetics approach. 
 
INTRODUCTION 
In tooth development, after early morphogenesis is complete, the biomineralization 
process takes place to form three composing hard tissues of a tooth: enamel, dentin, and 
cementum (Tucker and Sharpe, 2004; Nanci, 2008a; Thesleff, 2013). Dental enamel is formed 
through a developmental process, amelogenesis, which can be broken down into roughly two 
main stages: secretory and maturation stages. While the thickness of enamel is accomplished at 
secretory stage, the hardness is established at maturation stage of amelogenesis (Hu et al., 2007; 
Nanci, 2008b; Simmer et al., 2010; Bartlett, 2013). This developmental process requires intricate 
genetic regulations and coordination to build dental enamel with precise shapes and accurate 
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compositions. Therefore, disturbances of this process result in malformation of dental enamel 
(Winter and Brook, 1975; Witkop, 1988; Hu et al., 2007). 
Amelogenesis imperfecta (AI) is a group of inherited disorders with enamel 
malformations in the absence of non-dental phenotypes (isolated AI), although the term also 
refers to the enamel phenotype in syndromes (syndromic AI) (Witkop, 1988; Hu et al., 2007). 
The prevalence of AI ranges from 1:14,000 to 1:700, depending on various populations (Witkop 
and Sauk, 1976; Witkop, 1988). Patients afflicted with AI suffer from esthetic and functional 
burdens and have compromised quality of life (Coffield et al., 2005). Phenotypically, there are 
mainly three types of AI: hypoplastic, hypomaturation, and hypocalcified. While hypoplastic AI 
refers to a reduced thickness of dental enamel (thin enamel), hypomaturation AI suggests a 
hardness defect in dental enamel (soft enamel). Hypocalcified AI is a special form of AI in 
which the malformed enamel is of normal thickness but cheesy-soft, and may be lost soon after 
tooth eruption (Witkop, 1988; Aldred et al., 2003; Hu et al., 2007). Unraveling the genetic 
etiology of different types of AI will not only advance our understanding of normal enamel 
development but also provide a foundation for developing potential treatments for inherited 
enamel defects. 
The first several AI causative genes were identified with the appreciation that enamel 
matrix proteins and proteases people identified in developing teeth may play important roles in 
enamel formation. They were AMELX (amelogenin), ENAM (enamelin), KLK4 (Kallikrein-
Related Peptidase 4), and MMP20 (matrix metalloproteinase 20) (Aldred et al., 1992; Rajpar et 
al., 2001; Hart et al., 2004; Kim et al., 2005). However, defects in these genes only accounted 
for 25% or less of all isolated AI cases (Kim et al., 2006). Afterwards, with the realization that 
knowledge-based target gene approaches were not sufficient to comprehensively delineate the 
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genetic etiology of AI, people started to search for causative genes in AI kindreds through a 
genome-wide approach. FAM83H and WDR72 were two AI candidate genes identified in large 
AI kindreds by traditional linkage analysis and chromosome walking (Kim et al., 2008; El-Sayed 
et al., 2009). More recently, with the emergence of next-generation sequencing, the rate of 
identifying AI causative genes has been significantly accelerated. With whole exome 
sequencing, C4orf26 and SLC24A4 were identified to be associated with different types of 
isolated AI (Parry et al., 2012; Parry et al., 2013), and FAM20A a type of syndromic AI 
(O'Sullivan et al., 2011). Nevertheless, despite the fact that many candidate genes have been 
identified, there are about half of the AI cases of which the genetic causes are still unknown, 
indicating the genetic heterogeneity of AI and the complexity of enamel formation (Chan et al., 
2011). 
Our group has been working on mutational analysis of human inherited dental defects for 
decades, and Dr. Jan Hu has been actively recruiting families with these disorders. In this chapter 
of the thesis, we described 12 families and sporadic cases of different types of AI, and conducted 
mutational analyses to determine the genetic etiology of the disorder. We used a target gene 
approach with known AI candidate genes as well as whole exome sequencing when disease-
causing mutations could not be identified in these genes. Through this research, we aimed for not 
only expanding the mutational spectrum of known candidate genes but also identifying novel 
genes, which have never been known to be critical for enamel formation. 
 
RESULTS 
Family 1 – hypoplastic AI and a MMP20 mutation 
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Family 1 was a 3-generation family of which the male proband (III:2) was the only 
affected individual. His enamel was generally thin but radiographically contrasted well with 
dentin, suggesting a typical phenotype of hypoplastic AI (Fig. 3.1). Whole exome sequencing 
identified an apparent disease-causing mutation (g.15390A>G; c.611A>G; p.His204Arg) in both 
alleles of MMP20. This missense mutation changed a highly-conserved amino acid, His204, 
which was known to coordinate a structural zinc ion for MMP20 protease activity. The result of 
this work has been published (Wang et al., 2013b). 
 
Family 2 and 3 – hypoplastic AI and ITGB6 mutations 
The proband of Family 2 (III:1) was an 8-year-old Hispanic girl who was the only person 
with enamel malformation in the family (Fig. 3.2). Clinically, her teeth were spaced with reduced 
thickness of enamel and surface roughness. Panoramic radiograph showed that the enamel layer 
of unerupted teeth, particularly the bicuspids, was thin but contrasted well with dentin. This 
family was recruited many years ago and has been screened for mutations in all AI candidate 
genes with no positive results. 
The proband of Family 3, an 8-year-old Hispanic boy, (III:3) had a very similar enamel 
phenotype to that of Family 2 proband except that the maxillary incisors exhibited a 
“Hutchisonian” or screwdriver morphology (Fig. 3.3). In addition to dental phenotype, the 
proband was in good health but appeared to be undernourished with specific craniofacial features 
of anteverted pinnae and ptosis, suggesting a diagnosis of Nance–Horan syndrome (MIM 
#302350), a well-characterized X-linked syndrome that can explain all of the phenotypes in the 




Figure 3.1: Family 1 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree of family with a simplex pattern of inheritance. DNA was obtained from the five persons in 
the nuclear family (black dots). B: Oral photographs and bitewing radiographs of the proband at age 14 
yrs. Most of the occlusal enamel had abraded from the mandibular first molars. The radiographs show a 
thin layer of enamel that is only slightly more radio-opaque than dentin. C: DNA-sequencing 
chromatograms show that the parents were both heterozygous for the MMP20 c.611A>G transition 
mutation, while the proband was homozygous for the mutation (p.His204Arg) and his older brother was 
homozygous-normal. The sequence analysis determined that the mutation was inherited in a recessive 
pattern. This image is reproduced from Figure 2 of reference (Wang SK, Hu Y, Simmer JP, Seymen F, 
Estrella NM, Pal S, Reid BM, Yildirim M, Bayram M, Bartlett JD, Hu JC (2013). Novel KLK4 and 





Figure 3.2: Family 2 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. The proband (III:1) is the only person with enamel defects in the family. A dot marks the 
three study participants who donated samples for DNA sequencing. B: The proband at almost 8 years is in 
the mixed dentition stage with the permanent maxillary central incisors and all mandibular incisors and 
first molars erupted. Oral photographs of the proband show very little enamel covering dentin and signs 
of rapid attrition. C: Panoramic radiograph shows no contrasting enamel layer in erupted teeth and only a 
thin layer of enamel in unerupted teeth, which is characteristic of hypoplastic AI. D: Sequencing 
chromatograms of heterozygous ITGB6 mutations in Exon 4 (g.4545G>A; c.427G>A; p.Ala143Thr) and 
Exon 6 (g.27415T>A; c.825T>A; p.His275Gln). The proband was the only compound heterozygote. The 
father (II:2) had only the Exon 4 mutation; the mother (II:1) had only the Exon 6 mutation. The sequence 
variations are named relative to the ITGB6 genomic (NC_000002.11) and cDNA (NM_000888.3) 
reference sequences. R = G or A; W = A or T. This image is reproduced from Figure 1 of reference 
(Wang SK, Choi M, Richardson AS, Reid BM, Lin BP, Wang SJ, Kim JW, Simmer JP, Hu JC. ITGB6 
loss-of-function mutations cause autosomal recessive amelogenesis imperfecta. Hum Mol Genet 2013, 
Epub ahead of print) by permission of Oxford University Press. 
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suspected that the enamel defects might be a distinct phenotypic trait other than that of Nance–
Horan syndrome, which suggested a separate genetic defect contributing to the enamel 
phenotype. 
With whole exome sequencing of the two probands, we identified three integrin beta 6 
(ITGB6) mutations responsible for their enamel malformations. The family 2 proband was a 
compound heterozygote for two ITGB6 missense mutations (g.4545G>A, c.427G>A, 
p.Ala143Thr; g.27415T>A, c.825T>A, p.His275Gln), and the Family 3 proband had a ITGB6 
nonsense mutation (g.73664C > T c.1846C > T p.Arg616*) in both alleles in addition to a 
missense mutation in NHS gene (g.355444T>C, c.1697T>C, p.Met566Thr) responsible for the 
Nance–Horan syndrome. These are the first disease-causing ITGB6 mutations to be reported, 
demonstrating a significant role of integrin beta 6 in enamel formation. We also performed 
immunohistochemistry of ITGB6 on developing mouse teeth and showed its specific expression 
pattern at different stages of amelogenesis (Fig. 3.4). The result of this work has been published 
(Wang et al., 2013d). 
 
Family 4 – hypomaturation AI and a KLK4 mutation 
The proband of Family 4 (IV:1) was a 9-year-old girl from a first-cousin marriage. Her 
enamel was of normal thickness but appeared chipped-off on multiple teeth with brown 
discoloration and dental caries (Fig. 3.5). Radiographically, the enamel showed only slightly 
increased radiopacity than dentin, indicating a hypomaturation enamel defect. Whole exome 
sequencing identified a single-nucleotide deletion (g.6930delG; c.245delG; p.Gly82Alafs*87) in 




Figure 3.3: Family 3 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. The proband (III:3) is the only person with known enamel defects in the family. The 
proband’s father and uncle were reported by the mother to have ‘yellow teeth’ but their affection status is 
uncertain. A dot marks the three study participants who donated samples for DNA sequencing. B: The 
proband at age 8 is in the mixed dentition stage with all of the permanent maxillary and mandibular 
incisors and first molars erupted. Oral photographs of the proband show very little enamel covering dentin 
and signs of rapid attrition. C: Panoramic radiograph shows a thin, interrupted layer of contrasting enamel 
in some erupted teeth and a thin layer of continuous enamel in unerupted teeth. The mandibular left first 
molar is missing. D: Sequencing chromatograms of ITGB6 exon 11 (top) and NHS Exon 6 (bottom). The 
mother (II:3) was heterozygous for both of these sequence variations. Y = T or C. This image is 
reproduced from Figure 3 of reference (Wang SK, Choi M, Richardson AS, Reid BM, Lin BP, Wang SJ, 
Kim JW, Simmer JP, Hu JC. ITGB6 loss-of-function mutations cause autosomal recessive amelogenesis 




Figure 3.4: ITGB6 immunohistochemistry of Day 14 mouse mandibular incisors. 
A: The top left panel shows the cervical loop. Subsequent images move incisally. Single arrowheads mark 
ITGB6 signal along distal membrane of polarizing ameloblasts (note the varying levels of the nuclei and 
close proximity to the opposing sheet of odontoblasts). The early signal continues until the ameloblasts 
are fully polarized and the distance between the ameloblasts and odontoblasts has increased. ITGB6 
signal along the distal membrane diminishes and ends and ITGB6 appears to be internalized in secretory 
stage ameloblasts. Double arrowheads mark ITGB6 signal along the distal membrane in maturation stage 
ameloblasts. The signal along the distal membrane comes and goes, which presumably correlates with 
ameloblast modulations. B: Higher magnification view of ITGB6 along the distal membrane of 
differentiating ameloblasts. C: Higher magnification view of ITGB6 at the onset of enamel maturation. D: 
Higher magnification view of ITGB6 late in maturation stage. Note: blue is DAPI staining of nuclei; red 
is ITGB6 immunofluorescence; Od, odontoblasts; Am, ameloblasts. This image is reproduced from 
Figure 4 of reference (Wang SK, Choi M, Richardson AS, Reid BM, Lin BP, Wang SJ, Kim JW, Simmer 
JP, Hu JC. ITGB6 loss-of-function mutations cause autosomal recessive amelogenesis imperfecta. Hum 
Mol Genet 2013, Epub ahead of print) by permission of Oxford University Press. 
 
on the mutant transcript, which was predicted to undergo nonsense mediated decay. This was the 
second human KLK4 mutation reported so far. The result of this work has been published (Wang 





Figure 3.5: Family 4 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree of consanguineous family from Turkey with enamel malformations in the proband. B: 
Frontal, lateral, and occlusal photos of the proband at age 9 yrs. The enamel is chipped and shaded brown. 
C: Panorex radiograph of the mixed dentition showing enamel of normal thickness that contrasts only 
slightly with dentin. D: DNA sequencing chromatograms showing that the single-nucleotide deletion 
(c.245delG; position marked by arrowhead) is homozygous in the proband and heterozygous in his 
parents. This image is reproduced from Figure 1 of reference (Wang SK, Hu Y, Simmer JP, Seymen F, 
Estrella NM, Pal S, Reid BM, Yildirim M, Bayram M, Bartlett JD, Hu JC (2013). Novel KLK4 and 




Family 5 – hypomaturation AI and a SLC24A4 mutation 
The proband of Family 5 (II:1) was a 5.5-year-old Turkish girl from a consanguineous 
marriage (Fig. 3.6). Her primary teeth appeared creamy-yellow in color with extensive carious 
defects. The enamel was soft and chipped off from tooth surface. The lower central incisors were 
of normal thickness of dental enamel, suggesting the loss of enamel thickness was due to post-
eruption attrition. Radiographically, the enamel of unerupted permanent incisors and first molars 
showed full thickness but no contrast with underlying dentin, indicating a hypomaturation type 
of AI (Fig. 3.6). 
Whole exome sequencing identified a homozygous missense mutation in SLC24A4 
(g.124552C>A; c.437C>T; p.Ala146Val), a newly-identified AI candidate gene, which encodes 
a potassium-dependent sodium-calcium exchanger. The mutated Ala146 is strictly conserved 
between all the SLC24A and SLC8A homologs of many species, suggesting that the amino acid 
is critical for the function of SLC24A4 and that the identified mutation is disease-causing. This is 
the third disease-causing SLC24A4 mutation to be reported. We also performed 
immunohistochemistry of SLC24A4 on developing mouse teeth and showed its specific 
expression in maturation-stage ameloblasts, which demonstrated its critical role in enamel 
maturation (Fig. 3.7). The result of this work has been published (Wang et al., 2014b). 
 
Family 6 – syndromic hypomaturation AI and a STIM1 mutation 
The proband of Family 6 (IV:1) was a Turkish girl from a first-cousin marriage (Fig. 3.8). 
Soon after recruitment, the family moved to another country and was no longer contactable, so 




Figure 3.6: Family 5 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. The arrowhead marks the proband, the only affected individual in the consanguineous 
family. Dots mark the three persons who donated samples for DNA sequencing. B: Oral photographs of 
the proband (II:1) at age 5.5. The teeth are yellow or cream-colored, show signs of attrition and dental 
caries. C: Panorex of the proband at age 5.5. The enamel of erupting first molars exhibits normal 
thickness but no contrast with underlying dentin, indicating maturation enamel defects. D: Sequence from 
SLC24A4 Exon 5 showing the heterozygosity of the sequence variation g.124552C>A; c.437C>T; 
p.Ala146Val that occurred in the father (I:1) and mother (I:2) (left) and the homozygosity in the proband 
(II:1) (right). The mutation designations are with respect to the SLC24A4 genomic reference sequence 
NG_023408.1 and cDNA reference sequence NM_153646.3 (for mRNA transcript variant 1). Key: 
arrowhead: mutation point; Y: T or C. This image is reproduced from Figure 3 of reference (Wang SK, 
Choi M, Richardson AS, Reid BM, Seymen F, Yildirim M, Tuna EB, Gencay K, Simmer JP, Hu JC. 
STIM1 and SLC24A4 are critical for enamel maturation. J Dent Res 2014, Epub ahead of print) by 
permission of SAGE Journals. 
 
infections, but no immunological evaluation was performed. Her teeth looked creamy-brown, 




Figure 3.7: SLC24A4 immunohistochemistry of developing teeth of day 5 and 11 mice. 
A-E: At postnatal day 5 (PN5), SLC24A4 signal was observed in maturation stage ameloblasts at the 
incisal end of mandibular incisor and cusp tip of the first molar, and in skeletal muscles (A). High 
magnification views of differentiation and secretory stages toward the basal end of the mandibular incisor 
(B, C); transition to maturation stage (D); maturation stage (E). F-H: At postnatal day 11 (PN11), 
SLC24A4 signal was detected in the maxillary first molar where ameloblasts are in the maturation stage. 
I-K: At postnatal day 11 (PN11), only ameloblasts of the mandibular first and second molars (at 
maturation stage) were above the threshold for detection, but other tissues, including secretory stage 
ameloblasts (in the third molar and in the basal third of the incisor) were not (I). High magnification of 
secretory stage ameloblasts in a mandibular incisor (J, K). Key: Am: ameloblasts; Od: odontoblasts; P: 
pulp; SI: stratum intermedium. This image is reproduced from Figure 4 of reference (Wang SK, Choi M, 
Richardson AS, Reid BM, Seymen F, Yildirim M, Tuna EB, Gencay K, Simmer JP, Hu JC. STIM1 and 




attrition. Noticeably, nail dysplasia was evident on some fingers and toes, suggesting that the 
proband might be a case of syndromic AI. 
Whole exome sequencing identified a homozygous missense mutation in STIM1 
(g.232598C>T; c.1276C>T; p.Arg426Cys), of which loss-of-function mutations have been 
shown to cause severe immunodeficiency, congenital myopathy, and ectodermal dysplasia with 
enamel defects (Picard et al., 2009). The mutated amino acid (R426) is strictly conserved among 
vertebral STIM1 orthologs and is located within a critical functional domain of STIM1 protein, 
suggesting that the identified mutation is disease-causing. We also performed 
immunohistochemistry of STIM1 on developing mouse teeth and showed its specific expression 
in maturation-stage ameloblasts, which demonstrated its critical role in enamel maturation (Fig. 
3.9). The result of this work has been published (Wang et al., 2014b). 
 
Family 7 – hypocalcified AI and a FAM83H mutation 
The proband of Family 7 was a 10-year-old Turkish boy from a consanguineous marriage (Fig. 
3.10). He was the only individual with enamel malformations in the whole family, suggesting the 
disease was caused by a recessive or a de novo mutation. Clinically, the proband had a mixed 
dentition with enamel defects on both primary and permanent teeth. The malformed enamel was 
brown discolored, cheesy-soft, and chipped off from tooth surfaces. Most of the teeth showed 
extensive post-eruption attrition except the erupting lower right first premolar, which had a 
normal thickness of enamel. Radiographically, the enamel of unerupted teeth was of normal 





Figure 3.8: Family 6 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. Dots mark the three persons who donated samples for DNA sequencing. B: Oral 
photographs of the proband (IV:1) at age 6. The teeth are normal in size and shape, but are brown or 
cream-colored, and have undergone attrition. C: Photographs of the hands and feet showing nail 
dysplasia. D: Sequence from STIM1 Exon 10 revealing heterozygosity for the sequence variation 
g.232598C>T; c.1276C>T; p.Arg426Cys that occurred in the father (III:6) and mother (III:7) (top) and 
homozygosity in the proband (IV:1) (bottom). The mutation designations are with respect to the STIM1 
genomic reference sequence NG_016277.1 and cDNA reference sequence NM_001277961.1 (for mRNA 
transcript variant 1). Key: arrowhead: mutation point; Y: T or C. This image is reproduced from Figure 1 
of reference (Wang SK, Choi M, Richardson AS, Reid BM, Seymen F, Yildirim M, Tuna EB, Gencay K, 
Simmer JP, Hu JC. STIM1 and SLC24A4 are critical for enamel maturation. J Dent Res 2014, Epub 
ahead of print) by permission of SAGE Journals. 
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Figure 3.9: STIM1 immunohistochemistry of day 11 maxillary molars and mandibular 
incisor. A: Low magnification (40x) views of the maxillary first (M1), second (M2), and third (M3) 
molars. Boxes outline the higher magnification (100x) views in panels B and C. B: Maxillary first molar 
(M1) at 100x. The box outlines the higher magnification (200x) view in panel D. C: Maxillary second 
(M2) and third (M3) molars at 100x. The box outlines the highest magnification (400x) view shown in 
panel F. D: Distal cusp of M1 (200x). The box outlines the highest magnification (400x) view shown in 
panel E. E: Distal cusp tip of M1 (400x). F: Mesial cusp tip of M2 (400x). G: Longitudinal sections of a 
mandibular incisor (400x). Arrowhead marks the approximate onset of the maturation stage. Note that 
only maturation stage ameloblasts are positive for STIM1 in developing teeth. Secretory stage 
ameloblasts in M3 and the incisor are negative. Key: Am: ameloblasts; Od: odontoblasts; P: pulp; SI: 
stratum intermedium. This image is reproduced from Figure 2 of reference (Wang SK, Choi M, 
Richardson AS, Reid BM, Seymen F, Yildirim M, Tuna EB, Gencay K, Simmer JP, Hu JC. STIM1 and 




Whole exome sequencing of proband’s DNA identified no potential disease-causing 
mutations in all AI candidate genes except a nonsense mutation in FAM83H (g.10653C>T, 
c.1369C>T, p.Gln457*), which explained the enamel phenotype. However, neither of his parents 
carried this sequence variation, suggesting that it is a spontaneous de novo mutation. In 
consistency with previously reported mutations, this one was a nonsense mutation in Exon5 of 
FAM83H and was predicted to produce a truncated protein without its C-terminus. The analyzed 
exome sequencing data and the gene list of non-reference sequence variants were provided by 
Dr. Murim Choi. The FAM83H mutation confirmation with Sanger sequencing was conducted 
by Bryan Reid. 
 
Family 8, 9, 10, 11, and 12 – enamel-renal syndrome and FAM20A mutations 
In 2011, O’Sullivan et al. identified FAM20A mutations, as a cause of Amelogenesis 
Imperfecta and Gingival Fibromatosis Syndrome (AIGFS; MIM #614253), an autosomal 
recessive disorder characterized by severe enamel hypoplasia, failed tooth eruption, intrapulpal 
calcifications, and gingival hyperplasia (O’Sullivan et al., 2011). In our hands, we have recruited 
several AI families with these distinct phenotypes. However, interestingly, some of the probands 
from these families exhibited asymptomatic nephrocalcinosis in addition to the dental 
phenotypes of AIGFS. This finding suggested that FAM20A mutations may also cause Enamel-
Renal Syndrome (ERS; MIM #204690), an autosomal recessive disorder closely resembling 
AIGFS except for the additional phenotype of renal calcifications. 
Family 8, 9, 10, 11, and 12 are five AI families with distinct phenotypes of severely 




Figure 3.10: Family 7 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree: The proband (II:1) comes from a consanguineous marriage. B: FAM83H Exon 5 DNA 
sequencing chromatograms. The proband's parents (I:1 and I:2) and younger brother (II:1) were all wild-
type (WT) at cDNA position 1369. The proband (II:I) had a heterozygous c.1369C>T mutation 
of FAM83H. This mutation is a de novo nonsense mutation (g.10653C>T, c.1369C>T, p.Gln457*). The 
gene numbers start from the first nucleotide of the FAM83H reference sequence NG_016652.1. The 
cDNA numbers start from the translation initiation site of FAM83H reference sequence NM_198488.3. 
(The FAM83H chromatograms are courtesy for Bryan Reid.) 
 
and failed or delayed eruption of much of the permanent dentition, particularly the posterior teeth 
(Fig. 3.11; Fig. 3.12; Fig. 3.13; Fig. 3.14; Fig. 3.15). For kidney phenotypes, while probands 
from Family 9 and 10 exhibited nephrocalcinosis (Fig. 3.12), the proband of Family 11, at age of 
12, did not. We have not been able to obtain any information concerning kidney calcifications 
from Family 8 and 12. 
 By directly screening for FAM20A mutations in these families, we identified, in each 
case, recessive FAM20A mutations: Family 8 (c.992G>A; g.63853G>A; p.Gly331Asp), Family 9 
(c.720-2A>G; g.62232A>G; p.Gln241_Arg271del), Family 10 (c.406C>T; g.50213C>T; 
p.Arg136* and c.1432C>T; g.68284C>T; p.Arg478*), Family 11 (g.502011G>C; c.405-1G>C), 
and Family 12 (g.65094G>A; c.1207G>A; p.D403N), which demonstrated for the first time that 
FAM20A mutations cause ERS. All these 7 FAM20A mutations as well as other reported ones are 
expected to be loss-of-function mutations, although the function of FAM20A is still unknown. 




Figure 3.11: Family 8 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. A dot marks person who donated samples for DNA sequencing. B: FAM20A exon 7 DNA 
sequencing chromatograms. The proband's parents (II:1 and II:2) were both heterozygous (R = A or G) at 
cDNA position 992 (arrowheads). The proband (III-1) had the c.992G>A transition mutation in both 
alleles of FAM20A. This mutation changed a conserved glycine with an aspartic acid (p.G331D). The 
proband's affected younger sister (III-4) and her infant niece (IV:1) were also homozygous for this 
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mutation (not shown). II:1 and III:8 were heterozygous for a recognized polymorphism (rs2302234) in 
exon 7 (K = A or C) unrelated to the phenotype. C: Proband's panoramic radiograph. Note the many 
unerupted teeth. The mandibular and maxillary unerupted second molars show concave occlusal surfaces 
without enamel (arrowheads) D: Proband's oral photos. The maxillary central incisors are restored. The 
clinical crowns were short with hypoplastic enamel. There was a deep anterior overbite, a posterior cross-
bite, and retained mandibular primary molars (letters K, L, S, T). This image is reproduced from Figure 1 
of reference (Wang SK, Aref P, Hu Y, Milkovich RN, Simmer JP, El-Khateeb M, Daggag H, Baqain ZH, 
Hu JC (2013). FAM20A mutations can cause enamel-renal syndrome (ERS). PLoS Genet 9:e1003302.). 
 
 
Figure 3.12: Family 9 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree: a dot marks person who donated samples for DNA sequencing. B: FAM20A intron 4 DNA 
sequencing chromatograms. The proband's parents (IV:1 and IV:2) were both heterozygous (R = A or G) 
at cDNA position 720 (2 arrowheads). The proband (V:5) had the c.720-2A>G transition mutation in both 
alleles of FAM20A. This mutation is predicted to cause the skipping of exon 5, which is predicted to 
delete 31 amino acids (Q241-R271) from the protein without shifting the reading frame. C: Proband's oral 
photo showing enamel hypoplasia, gingival enlargement and failed eruption. D: Proband's panoramic 
radiograph. Note the enamel hypoplasia, pulp calcifications, and unerupted teeth with pericoronal 
radiolucencies delimited by sclerotic borders. The left mandibular second molar (#18) shows apparent 
crown resorption. E: Ultrasound of proband's right kidney, located to the right of the yellow line. This 
image is reproduced from Figure 2 of reference (Wang SK, Aref P, Hu Y, Milkovich RN, Simmer JP, El-
Khateeb M, Daggag H, Baqain ZH, Hu JC (2013). FAM20A mutations can cause enamel-renal syndrome 




Figure 3.13: Family 10 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree consistent with a recessive pattern of inheritance. B: Exon 2 (left) and exon 11 DNA 
sequencing chromatograms. The proband (III:16) is heterozygous for nonsense mutations in exon 2 
(c.406C>T) and exon 11 (c.1432C>T). The unaffected brother (III:17) is only heterozygous for the 
c.406C>T mutation in exon 2. C: Panoramic radiograph of proband. Note the lack of enamel, pericoronal 
radiolucencies over the unerupted mandibular third molars (arrowheads), and apparent crown resorption 
of the left mandibular second molar (#18). This image is reproduced from Figure 3 of reference (Wang 
SK, Aref P, Hu Y, Milkovich RN, Simmer JP, El-Khateeb M, Daggag H, Baqain ZH, Hu JC (2013). 




Figure 3.14: Family 11 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. Dots mark the five persons who donated samples for DNA sequencing. Triangles represent 
stillborns. B: Oral photographs of the proband (III:7) at age 2.5 yrs. C: Oral photographs of the proband 
at age 8.5 yrs. The anterior incisors are present and exhibit severe enamel hypoplasia. The white cuspids 
are dental restorations. The attached gingiva is enlarged, but the impression is enhanced by the small sizes 
of the clinical crowns. D: Panorex of the proband at age 11.5 yrs. Enamel is missing or does not contrast 
with dentin throughout. Most tooth roots are short, and eruption is less than expected. Pulp stones are 
observed in many teeth, particularly in the first molars. E: Oral photographs of the proband at age 13 yrs. 
The gingival hyperplasia is minimal and could readily be missed in an oral examination. F: DNA 
sequencing chromatograms of Family 1. Top: Sequence from the border of Exon 1 and Intron 1, revealing 
heterozygosity for a splice junction mutation (g.502011G>C; c.405-1G>C) that occurred in the mother 
and proband. Bottom: Exon 8 sequence revealing heterozygosity for a missense mutation (g.65094G>A; 
c.1207G>A; p.D403N) that occurred in the father and proband. The unaffected brother (III:5) and sister 
(III:8) had neither of these mutations (data not shown). The mutation designations are with respect to 
the FAM20A genomic reference sequence NG_029809.1 and cDNA reference sequence NM_017565.3 
(for mRNA transcript variant 1). Key: arrowhead = mutation point; R = A or G; S = G or C. This image is 
reproduced from Figure 1 of reference (Wang SK, Reid BM, Dugan SL, Roggenbuck JA, Read L, Aref P, 
Taheri AP, Yeganeh MZ, Simmer JP, Hu JC (2014). FAM20A Mutations Associated with Enamel Renal 





Figure 3.15: Family 12 pedigree, enamel defects, and disease causing mutations. 
A: Pedigree. Dots mark the five persons who donated samples for DNA sequencing. Triangles represent 
stillborns. B: Oral photographs of the proband (V:I) at age 10 yrs. C: Panorex radiograph taken when the 
girl was 10 yrs old. D: Bitewings and periapical radiographs taken when the girl was 9 yrs old. E: DNA 
sequencing chromatograms for Family 2. Top: Sequencing chromatogram from the border of Exon 10 
and Intron 10 revealing heterozygosity for a splice junction deletion (g.66622del; c.1361+4del) in the 
proband’s unaffected aunt (IV:2), mother (IV:7), and the sister (V:2). Bottom: Sequencing chromatogram 
from the border of Exon 10 and Intron 10 revealing homozygosity for a splice junction deletion 
(g.66622del; c.1361+4del) in the proband (V:1) and her affected father (IV:6). The mutation designations 
are with respect to theFAM20A genomic reference sequence NG_029809.1 and cDNA reference sequence 
NM_017565.3 (for mRNA transcript variant 1). This image is reproduced from Figure 2 of reference 
(Wang SK, Reid BM, Dugan SL, Roggenbuck JA, Read L, Aref P, Taheri AP, Yeganeh MZ, Simmer JP, 
Hu JC (2014). FAM20A Mutations Associated with Enamel Renal Syndrome. J Dent Res 93:42-8.) by 




molars lacked true enamel, showed extensive crown and root resorption, hypercementosis, and 
partial replacement of resorbed mineral with bone or coalesced mineral spheres (Wang et al., 
2013a). Along with nephrocalcinosis in some cases, these findings suggested a critical role of 
FAM20A in the regulation of biomineralization processes. In addition, we performed 
immunohistochemistry of FAM20A in developing mouse heads and adult kidneys, and localized 
FAM20A in secretory-stage ameloblasts, odontoblasts, tooth eruption pathway, and in renal 
tubules of the kidney, which explained some of the disease phenotypes (Fig. 3.16). The result of 
this work has been published in 2 papers (Wang et al., 2013a; Wang et al., 2014a). 
 
DISCUSSION 
Hypoplastic AI and MMP20 mutations 
Hypoplastic AI refers to a thickness defect of dental enamel (thin enamel). Since the full 
thickness of enamel is established by appositional growth during secretory stage of 
amelogenesis, hypoplastic AI is usually caused by mutations in genes which play a significant 
role at the secretory stage, such as genes encoding enamel matrix proteins, AMELX (amelogenin) 
and ENAM (enamelin) (Hu et al., 2007). Noticeably, an enamel-specific protease, MMP20, is 
also expressed by secretory-stage ameloblasts (Hu et al., 2002). To date, there are a total of 7 
disease-causing MMP20 mutations reported, including the one we identified in our Family 1 
(Gasse et al., 2013). All of them appear to be loss-of-function mutations, suggesting that failed 
proteolytic processing of enamel matrix proteins at secretory stage is the cause of enamel 




Figure 3.16: FAM20A immunohistochemistry. 
Top: FAM20A localization during mouse first maxillary molar development. A1-A3: At post-natal day 5 
(PN5), FAM20A signal was observed in secretory-stage ameloblasts, odontoblasts, and in oral epithelium 
(A3). B1-B4: At post-natal day 8 (PN8), FAM20A signal was minimal in transition or early maturation-
stage ameloblasts, but strong in odontoblasts and the oral epithelium (B2 and B4). C1-C2: At post-natal 
day 11 (PN11), no FAM20A signal was observed in maturation-stage ameloblasts. FAM20A was 
detected in odontoblasts and in oral epithelium. A band of cells positive for FAM20A was observed in the 
connective tissue between the oral epithelium and the developing cusp tip. The box in C1 corresponds to 
the position of panel C2. C3: On post-natal day 14 (PN14), just prior to eruption, FAM20A signal was 
evident in the dental follicle above the molar cusp tips. D1-D3: FAM20A localization in four-week-old 
mouse kidney. Key: bc, Bowman’s capsule; c, renal cortex; m, renal medulla; oe, oral epithelium. Blue is 
DAPI-stained nuclei, green is FAM20A signal, solid arrowheads indicate ameloblasts, and hollow 
arrowheads indicate odontoblasts. This image is reproduced from Figure 4 of reference (Wang SK, Reid 
BM, Dugan SL, Roggenbuck JA, Read L, Aref P, Taheri AP, Yeganeh MZ, Simmer JP, Hu JC (2014). 




For instance, while the proband of Family 1, who had a p.His204Arg MMP20 mutation, showed 
a typical hypoplastic AI phenotype with very thin enamel, the patient with p.Thr130Ile mutation 
reported by Gasse et al. had a typical hypomaturation AI phenotype (Gasse et al., 2013). Some 
cases even showed combined hypoplastic-hypomaturation phenotypes (Papagerakis et al., 2008). 
Theoretically, one would expect that loss-of-function mutations in genes encoding 
enamel matrix proteases, MMP20 and KLK4, would impede ion deposition at maturation stage 
due to defective protein degradation and lead to hypomaturation AI. However, the hypoplastic 
phenotype of Family 1 proband and the thin enamel of Mmp20 null mice suggest that MMP20 
may have functions other than degradation of matrix protein during secretory stage of enamel 
formation (Caterina et al., 2002). It has been shown that Mmp20 is expressed by preameloblasts, 
secretory-stage ameloblasts, and odontoblasts and the protease concentrates at the dentino-
enamel junction (DEJ) in developing teeth (Hu et al., 2002; Wang et al., 2013c). Therefore, it is 
possible that MMP20 might be responsible for degrading the basement membrane (BM) prior to 
the secretory stage, and that failed BM degradation due to defective MMP20 function might 
impede matrix secretion and lead to a hypoplastic phenotype. However, further investigations 
need to be conducted to test this hypothesis. 
 
Hypoplastic AI and ITGB6 mutations 
We reported the first human ITGB6 (integrin beta 6) mutations causing autosomal 
recessive hypoplastic AI. Along with the enamel defects in Itgb6 null mice, our finding 
demonstrated a significant role of integrin β6 in enamel formation (Wang et al., 2013d). 
Moreover, our immunohistostaining of mouse developing incisors showed that ITGB6 was 
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present on the ameloblast distal membrane at the onset of enamel formation and during 
formation of the initial enamel, and appeared to be internalized about the time ameloblasts 
developed their Tomes’ processes (Fig. 3.4). This window of expression, along with the previous 
finding that Itgb6 null mice overexpressed the secreted enamel proteins amelogenin (21-fold) 
and enamelin (7.6-fold) but failed to make enamel rods, suggests that ITGB6 signaling regulates 
the onset of enamel formation by repressing the expression of enamel proteins and also regulates 
formation of the Tomes’ process (an ameloblast distal membrane structure necessary for enamel 
rod/interrod organization) (Mohazab et al., 2013; Wang et al., 2013d). 
Several integrins have been shown to be expressed at different stages of murine tooth 
development, including ITGA6 and ITGB4 (integrin α6β4), two protein components of 
hemidesmosome-anchoring filament complexes (Salmivirta et al., 1996). Mutations in genes 
encoding these hemidesmosome complex proteins (LAMA3, LAMB3, LAMC2, COL17A1, ITGA6 
and ITGB4) cause junctional epidermolysis bullosa (JEB) in which enamel defects are one of the 
manifestations (Masunaga, 2006; Fine, 2010). Also, heterozygous carriers with these genetic 
defects were also reported to have enamel malformations without non-dental phenotypes. In this 
case, the affected enamel usually shows pitted defects instead of generalized hypoplasia (Kim et 
al., 2013; Poulter et al., 2014). However, in contrast, our patients with recessive ITGB6 
mutations exhibited generalized hypoplastic enamel, suggesting that integrin β6, unlike integrin 
α6β4, may have functions other than mechanically attaching epithelium to extracellular matrices 
by hemidesmosome protein complexes. 
Soon after we reported the ITGB6 mutations, Poulter et al. also reported an ITGB6 
mutation (p.Pro196Thr) causing enamel defects (Poulter et al., 2013). However, the patient’s 
enamel phenotype was quite different from those of our two cases. While our patients showed 
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generalized hypoplastic enamel, theirs had a phenotype of pitted hypomineralised AI. The basis 
of this phenotypic difference is unclear. More cases of ITGB6 mutations and further 
investigations are needed to elucidate the pathological mechanism of ITGB6-associated AI. 
 
Enamel maturation and hypomaturation AI 
The hardness of dental enamel is established at the maturation stage of amelogensis, in 
which two principal activities were involved: degradation and re-absorption of the organic matrix 
and regulated movement of ions into and out of the matrix (Smith, 1998; Hu et al., 2007; Simmer 
et al., 2010). During the maturation stage, residual enamel proteins are degraded by KLK4 and, 
to a lesser extent, by MMP20. Therefore, mutations in KLK4 and MMP20 can cause 
hypomaturation AI (Hart et al., 2004; Kim et al., 2005). In this study, we reported the second 
human KLK4 mutation (g.6930delG; c.245delG; p.Gly82Alafs*87), which reaffirmed the 
significant role of KLK4 in matrix protein degradation and enamel maturation (Wang et al., 
2013b). 
In addition to degradation and re-absorption of the residual proteins, ion deposition, 
particularly calcium ion, onto the sides of enamel crystallites is the fundamental basis of enamel 
maturation. However, the underlying mechanism of calcium transport during amelogenesis is 
still largely unknown. STIM1 (stromal interaction molecule 1) and ORAI1 (ORAI calcium 
release-activated calcium modulator 1) mediate store-operated calcium entry (SOCE), which is a 
Ca2+ influx pathway critical for the normal functioning of many cell types, including T cells, 
muscle cells, and ameloblasts (Shaw et al., 2013; Collins et al., 2013). SLC24A4 is a potassium-
dependent sodium-calcium exchanger reported to be expressed by ameloblasts (Hu et al., 2012). 
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Genetic defects in human STIM1, ORAI1, and SLC24A4 cause hypomaturation AI, 
demonstrating the critical roles of these three proteins in calcium transport during enamel 
maturation (Feske et al., 2006; Picard et al., 2009; Parry et al., 2013). In this study, we identified 
novel STIM1 and SLC24A4 mutations in families with hypomaturation AI and showed, by 
immunohistostaining, that these two genes were specifically expressed by maturation-stage but 
not secretory-stage ameloblasts (Fig. 3.7; Fig. 3.9), suggesting that there are important 
differences in the calcium transcellular transport systems employed by secretory and maturation 
stage ameloblasts. We also proposed a working hypothesis that explains how calcium from the 
blood supply might be drawn through maturation stage ameloblasts to support mineralization 
(Wang et al., 2014b). Perhaps SLC24A4 is responsible for the active transport of calcium ions 
out of the cell and into the enamel matrix by using the energy of a Na+ gradient, which in turn 
lowers intracellular Ca2+, depletes ER stores, and activates the SOCE system (STIM1/ORAI1) to 
replenish intracellular Ca2+ stores at the proximal side of maturation stage ameloblasts, nearest 
the blood supply (Wang et al., 2014b). 
 
Autosomal dominant hypocalcified AI and FAM83H mutations 
Since the first FAM83H mutations were identified to cause autosomal dominant 
hypocalcified AI (ADHCAI) in 2008 (Kim et al., 2008), many ADHCAI kindreds and disease-
causing FAM83H mutations have been sequentially reported (Fig. 1.4). In Family 7, we 
identified a novel FAM83H mutation (p.Gln457*). Interestingly, all these disease-causing 
FAM83H mutations are either nonsense mutations or frameshifts leading to a premature stop 
codon. No other types of loss-of-function mutations have been reported. Also, all the reported 
mutations are located at a specific 5’ region of Exon 5 (the last exon) and expected to produce a 
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truncated FAM83H protein with a specific range of lengths (from 287 to 694 amino acids) (Fig. 
1.4). This genetic homogeneity of mutational spectrum highly suggests a dominant negative 
effect or a “gain-of-function” rather than haploinsufficiency as the pathological mechanism of 
ADHCAI. 
This hypothesis is further supported by the reported nonsense sequence variants of 
FAM83H in general population. According to dbSNP, 1000 Genome Project, and NHLBI Exome 
Sequencing Project databases, several nonsense FAM83H mutations in earlier exons (Exons 2, 3, 
and 4) have been identified in general populations, with one of which (p.Gln201*; rs189033490) 
has a minor allele frequency of 0.1%. These early nonsense mutations, unlike those at the last 
exon, are expected to produce a mutant transcript which will undergo nonsense mediated decay 
and lead to a complete null allele. In other words, loss of half FAM83H doses seems not to cause 
a disease phenotype, meaning haploinsufficiency is not the pathological mechanism of 
ADHCAI. In contrast, only truncation mutations between p.Ser287* and p.Glu694* were 
reported to be disease-causing, which supports the hypothesis of dominant negative effects. For 
nonsense mutations at further 3’ end of FAM83H Exon 5 (longer than p.Glu694*), there are two 
(p.Glu883*, p.Glu1156*) reported so far in COSMIC (Catalogue of Somatic Mutations in 
Cancer) database, suggesting that these mutations seem not to cause a disease phenotype as those 
at earlier exons. 
In Chapter 4, we will discuss the molecular characterization of FAM83H protein and 
propose a working hypothesis of why only mutations between p.Ser287* and p.Glu694* are 




AIGFS, ERS, and FAM20A mutations 
In this thesis, we reported 6 novel and 1 reported FAM20A mutations in 5 families and 
demonstrated that Enamel-Renal Syndrome (ERS) are caused by FAM20A mutations. Based 
upon the similar dental phenotypes between AIGFS and ERS, we also proposed that these two 
disorders may be of the same disease entity but with variable presentation of nephrocalcinosis 
(Wang et al., 2013a; Wang et al., 2014a). 
FAM20A belongs to a small gene family that in human and mouse has three members: 
FAM20A, FAM20B, and FAM20C. Proteins encoded by this gene family are all predicted to have 
a potential kinase domain (Nalbant et al., 2005). FAM20B was the first one in the family shown 
to have kinase activity: FAM20B was demonstrated to be a xylose kinase, required in the Golgi 
for the efficient addition of glycan attachments on secreted proteins (Koike et al., 2009). More 
recently, FAM20C was identified as Golgi Casein Kinase (GCK) responsible for 
phosphorylation of many SCPP proteins (secretory calcium-binding phosphoproteins) critical for 
biomineralization (Tagliabracci et al., 2012). Genetic defects in human FAM20C cause Raine 
syndrome (OMIM #259775), an autosomal recessive disorder characterized by major defects in 
biomineralization (Simpson et al., 2007). In terms of FAM20A, although its defects have been 
shown to cause AIGFS and ERS (O'Sullivan et al., 2011; Jaureguiberry et al., 2012; Wang et al., 
2013a), its actual function is still unknown. To date, all the FAM20A mutations are loss-of-
function mutations, with some of which are missense mutations of only one amino acid 
substitution (Wang et al., 2014a). Particularly, some of these missense mutations happen at an 
amino acid position in which corresponding FAM20C mutations cause loss of kinase activity. 
For example, the FAM20A mutation (p.Asp403Asn) we identified in Family 11 has a 
corresponding FAM20C mutation (p.Asp451Asn) which has been shown to abolish FAM20C 
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kinase activity in vitro and to be disease-causing (Wang et al., 2014a). These missense mutations 
highly suggest that FAM20A is also a kinase, although its substrates still need to be identified. 
Assuming that FAM20A is indeed a kinase, our immunohistostaining further suggests a 
significant role of FAM20A-dependent phosphorylations in different stages of tooth and enamel 
development (Fig. 3.16). We demonstrate that FAM20A is expressed by secretory-stage but not 
maturation-stage ameloblasts, which explains the hypoplastic enamel phenotype, when both 
FAM20A alleles are defected. FAM20A is expressed in the dental follicle just above the molar 
cusp tips and absence of FAM20A causes failures in tooth eruption, suggesting that FAM20A-
dependent phosphorylations may play a role in forming eruption pathways, although, tooth 
eruption seems to be relatively unaffected in the human primary dentition and in Fam20a null 
mice (Vogel et al., 2012). Gingival fibromatosis is another feature often reported in FAM20A 
mutation patients. This manifestation might be associated with FAM20A expression in selected 
cells within the gingival tissues, rather than in the oral epithelium. We show that some FAM20A 
mutation patients have asymptomatic nephrocalcinosis and find FAM20A expression in renal 
tubules of adult mouse kidneys. Fam20a null mice exhibited widespread and severe ectopic 
calcification throughout the body, but most prominantly in the kidneys. Normal blood calcium 
and phosphorus in mutant mice and human patients suggested that the ectopic calcification might 
be caused by local rather than systemic effects (Vogel et al., 2012). 
 
Phenotypic and genotypic heterogeneity in AI 
To date, many candidate genes, including AMELX, ENAM, MMP20, KLK4, FAM83H, 
WDR72, C4orf26, SLC24A4, and LAMB3, have been identified to be associated with isolated AI. 
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However, the genetic defects of about half of the AI cases are still unknown, indicating that there 
are more genes involved in amelogenesis waiting to be identified (Chan et al., 2011). This high 
genetic heterogeneity of AI also suggests that amelogenesis is a delicate developmental process 
which is highly susceptible to many genetic and environmental alterations. For instance, 
FAM83H and WDR72 are expressed by many tissues other than developing teeth. However, 
Patients with genetic defects in these two genes only show enamel malformations without 
clinically-detectable manifestations in non-dental tissues, suggesting the vulnerability of enamel 
formation (Kim et al., 2008; El-Sayed et al., 2009). Moreover, just because of this vulnerability, 
many syndromes have AI as one of the manifestations (Hu et al., 2007; Cobourne and Sharpe, 
2013). However, it is important for us to differentiate if the enamel defects in syndromes are due 
to primary or secondary effects. Many syndromes with kidney problems are also associated with 
enamel defects due to defective ion regulation (Subramaniam et al., 2012). In other words, the 
enamel phenotype comes from the secondary effect of impaired renal functions rather than the 
genetic defect having direct impact on enamel formation. 
In addition to genotypic heterogeneity, there is also high variability in AI phenotypes. As 
we mentioned previously, there are mainly three types of AI, featured by different characteristics 
of enamel defects. Even with the same genetic defects, the phenotypes can still be highly 
variable. MMP20-associated enamel defects are the best example of this high phenotypic 
variability (See the above discussion section of MMP20 mutations). Sometimes, this variation is 
further exaggerated by the post-eruptional changes, such as discoloration and attrition. Therefore, 
for mutational analysis of AI, it is not practical to establish genotype-phenotype correlation due 
to high genotypic and phenotypic heterogeneities, which poses a problem in defining genetic 
etiology of many AI cases, especially the sporadic ones. Outside this thesis, our lab also analyzed 
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the exomes from the probands of different AI families separately and then collectively but still 
failed to identify the genetic defects in about half of the cases, although it is possible that the 
mutations are at the regulatory region of the gene, which is not easy to identify. 
 
Prospects in mutational analysis of AI 
As we discussed in Chapter 2 (mutational analysis of familial tooth agenesis), due to the 
genotypic and phenotypic heterogeneity of the disease, the genetic etiology of a significant 
number of cases still waits to be determined. In the future, for large-sized families, we should 
take advantage of the genetic linkage power and analyze with exome sequencing data to identify 
the disease-causing mutations. For small families or sporadic cases, we need to recruit multiple 
families with relatively similar phenotypes and collectively analyze their exome data at a 
“genetic pathway level.” 
Furthermore, enamel defects found in specific gene knockout mice can be highly 
suggestive of potential AI candidate genes in humans. For instance, we established ITGB6 as a 
candidate gene for isolated AI, based upon the report that Itgb6 null mice exhibited enamel 
malformations (Mohazab et al., 2013). This approach demonstrates the power of reverse genetics 
(from genotype to phenotype) in unraveling the genetic etiology of human AI. Therefore, mouse 
models may provide supportive evidence for AI candidate genes we identify through human 
mutational analysis. Recently, the knockout mouse project (KOMP) and KOMP phenotyping 
plan were funded by National Human Genome Research Institute (NHGRI) and National Center 
for Research Resources (NCRR). These projects include a concerted, centralized, high-
throughput phenotyping effort to extend the scientific value of the knockout ES cell resources, 
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which is also a precious resource for human genetics (Ayadi et al., 2012; White et al., 2013). 
Unfortunately, characterization of the dental phenotype is not part of these projects. If knockout 
mice could be routinely screened for apparent dental phenotypes, it could significantly advance 
our understanding of normal and pathological tooth development. 
 
MATERIALS AND METHODS 
For “Family recruitment and ethics statement,” “Phenotypic data collection and family 
pedigree construction,” “DNA extraction from blood and saliva samples,” and “Mutational 
analysis (target gene approach),” please refer to the same sections in Chapter 2. 
 
Mutational analysis (whole exome sequencing) 
Whole exome sequencing was conducted at Yale Center for Genome Analysis (West 
Haven, CT, U.S.A.) and Edge BioSystems (Gaithersburg, MD, U.S.A.). For experimental 
processes at Yale Center for Genome Analysis, please refer to the same section in Chapter 2. For 
whole exome sequencing in Edge BioSystems, exome capture was conducted with Aligent 
SureSelect Target Enrichment System (Agilent Technologies; Santa Clara, CA, U.S.A.). For 
sequencing, 3μg of genomic DNA was nebulized into ~300 bp fragments, which were tailed and 
ligated to adapters, amplified, and analyzed using an Agilant 2100 Bioanalyzer prior to 
sequencing in paired-end reads, 75-100 bases per read (Life Technologies SOLiD™ System; 




Tissue preparation and sample sectioning for immunohistochemistry 
Postnatal day 5, 8, 11, and 14 mouse heads were quickly dissected of skin, cut in half, 
and immersed in 4% paraformaldehyde fixative overnight at 4°C, washed in PBS 4-5 times at 
4°C, and decalcified at 4°C by immersion in 1 L of 4.13% disodium ethylenediaminetetraacetic 
acid (EDTA, pH 7.3) with agitation. The EDTA solution was changed every other day for 8-9 d 
for day-5 mice, 19-21 d for day-8 mice, and 30 d for day-11 and day-14 mice. Kidneys from 4-
week-old mice were dissected and fixed as described above. For cryosectioning, after 
decalcification the tissues were immersed in 30% sucrose overnight for cryoprotection and 
embedded in OCT/Tissue Tek (Sakura Finetek; Torrance, CA, U.S.A.). The blocks were 
cryosectioned at 10μm thickness at -20 °C. For paraffin-sectioning, samples underwent regular 




For paraffin sections, prior to immunostaining, the sections were deparaffinized and heat-
treated (95°C) with antigen retrieval solution (ab973; Abcam; Cambridge, MA, U.S.A.) for 30 
min. For cryosections, the slides can be proceeded directly for immunostaining without 
prerequisite preparation. 
The slides were rinsed with PBT buffer (0.1% Triton X-100 in PBS), blocked with 5% 
sheep serum (S22; Millipore Corporation; Billerica, MA, U.S.A.) in PBT for 30 min at room 
temperature, and serial sections were incubated overnight with primary antibodies in blocking 
solution. The sections were washed with PBT for 15 min and incubated for 30 min at room 
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temperature in solutions containing anti-rabbit IgG secondary antibody conjugated with Alexa 
Fluor 594 (1:500; A-11012; Molecular Probes® by Life Technologies). Sections were rinsed in 
PBT for 15 min, mounted with ProLong® Gold antifade reagent with DAPI (P-36941; Molecular 
Probes® by Life Technologies), and examined using an Olympus BX51 with fluorescence 
attachments and photographed using an Olympus DP71 camera with DP controller and manager 
software. 
Primary antibodies used for immunohistochemistry include: anti-ITGB6 (HPA023626) 
(1:100), anti-FAM20A (SAB2100759) (1:100), anti-STIM1 (HPA012123) (1:100) from Sigma-
Aldrich (St. Louis, MO, U.S.A.); anti-SLC24A4 (ab136968) (1:100) from abcam® (Cambridge, 
MA, U.S.A.) 
 
Characterization of extracted teeth from Family 10 proband 
The Micro-CT, SEM, and Backscatter SEM analyses were performed by Dr. Yuanyuan 
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MOLECULAR CHARACTERIZATION OF FAM83H 
 
ABSTRACT 
Recently, mutations in FAM83H (family with sequence similarity 83, member H) were 
identified to cause autosomal dominant hypocalcified amelogenesis imperfecta (ADHCAI). All 
of the 20 disease-causing mutations reported so far are expected to truncate FAM83H from 1179 
to between 287 and 694 amino acids. This genetic homogeneity of the FAM83H mutational 
spectrum strongly suggested a dominant negative effect in the pathogenesis of ADHCAI. 
Although human mutational studies revealed the physiological function of FAM83H in enamel 
development, the functions of FAM83H in cellular and molecular levels are still largely 
unknown. Here, we used a biochemical approach to study FAM83H protein-protein interactions 
and the intracellular localization of wild-type and mutant FAM83Hs. We found that FAM83H 
interacts with itself, which suggested that the mutant protein may exert the dominant negative 
effect through interacting with the wild-type protein and prevent it from functioning. We also 
demonstrated that FAM83H interacts with casein kinase 1 (CK1) via an F-X-X-X-F-X-X-X-F 
sequence motif in its N-terminus and with SEC16A via a binding domain in the middle of the 
protein. With SEC16A being a protein component of COP II complex and involved in ER-to-
Golgi membrane trafficking, we proposed that FAM83H may serve as a scaffold protein for 
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localizing CK1 to SEC16A so that CK1 can facilitate membrane trafficking at the ER exit site. 
We hypothesized that a truncated FAM83H that can bind to CK1 but not SEC16A will fail to 
correctly localize CK1, will disturb proper vesicle trafficking and protein transport from ER to 
Golgi, and lead to pathological enamel formation. Our study not only reveals a potential cellular 
function of FAM83H, but also provides a plausible pathological mechanism of ADHCAI 
through a dominant negative effect from mutant truncated FAM83H proteins. 
 
INTRODUCTION 
Mutational analysis of human hereditary enamel defects had been using target gene 
approaches of candidate genes encoding enamel matrix proteins and proteases that scientists had 
identified biochemically within developing enamel (Kim et al., 2006). Few genome-wide 
approaches have been applied until recently. In 2007, by means of linkage analysis, Mendoza et 
al. mapped a new AI locus to chromosome 8q24.3 (Mendoza et al., 2007). Based upon this 
linkage data, our group identified mutations in a novel gene, FAM83H, responsible for autosomal 
dominant hypocalcified amelogenesis imperfecta (ADHCAI) (Kim et al., 2008), a specific form 
of AI in which the affected enamel is cheesy-soft and easily peeled off after tooth eruption. 
Subsequently, many disease-causing FAM83H mutations were reported by different groups, and 
FAM83H-associated AI seemed to be the most prevalent AI in North America (Lee et al., 2008; 
Hart et al., 2009; Wright et al., 2009; Hyun et al., 2009; El-Sayed et al., 2010; Lee et al., 2011; 
Wright et al., 2011; Haubek et al., 2011; Song et al., 2012). 
FAM83H (family with sequence similarity 83, member H) encodes a protein of 1179 
amino acids with a calculated molecular mass of 127-kDa (Kim et al., 2008). Unlike all of the 
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enamel matrix proteins and proteases known to be important for enamel formation, FAM83H 
does not have a signal peptide and is expected to be a non-secreted intracellular protein. 
However, the primary structure of FAM83H gives little indication of its potential function. 
Based upon bioinformatic structure and domain prediction, FAM83H has neither well-defined 
structural characteristics nor known functional domains except an N-terminal phospholipase D-
like (PLD-like) domain, which is the shared element among all the members in FAM83 family 
and gives the group its identity (Fig. 4.1A). However, the homology between this domain and 
PLD is trace and probably only indicative of a similar three-dimensional fold. Therefore, it is 
very unlikely that FAM83H has PLD-like enzymatic activity (Ding et al., 2009). 
To date, 20 novel disease-causing mutations have been identified, and some have been 
reported more than once (Fig. 1.4). Noticeably, all the reported mutations are either nonsense 
mutations or frameshifts leading to a premature stop codon. No other types of loss-of-function 
mutations, such as missense mutations, have been reported to be disease-causing. More 
interestingly, all the FAM83H mutations are located within a specific 5’ region of its last exon 
(Exon 5) and are predicted to generate a mutant transcript that can escape nonsense mediated 
decay and produce a truncated protein ending between amino acids 287 and 694 (Fig. 1.4; Fig. 
4.1B, C). This mutational homogeneity highly suggests a dominant negative effect or a gain of 
function in the pathogenesis of ADHCAI. In contrast, haploinsufficiency is the less plausible 
pathological mechanism, since other types of loss-of-function mutations seem not to cause a 
disease phenotype. 
So far, human mutational studies are the main evidence indicating the physiological 
significance of FAM83H. However, the actual functions of this protein inside the cell and the 




















Figure 4.1 (E) 
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Figure 4.1: Protein sequence alignment of FAM83H orthologs from 7 vertebrates. 
Asterisks (*) mark identical amino acids. The N-terminal PLD-like domain (amino acid 4-281 in human 
FAM83H) is underlined (A). Ser287 (the most N-terminal mutation) and Glu694 (the most C-terminal 
mutation) are marked red/bold (B, C). All the other nonsense mutations are marked blue/bold (B, C). 
Three phenylalanines (bold) of F270-X-X-X-F274-X-X-X-F278 motif are located at a highly conserved 
region right N-terminal to Ser287 (yellow-highlighted) (B). A conserved region N-terminal to Glu694 is 
highlighted with green (C), and two conserved areas at C-terminal end of FAM83H with blue (E). Protein 
sequences are from human (Hum) (Homo sapiens; gi|157311635, ref|NP_940890.3), cow (Bos taurus; 
gi|119906195, ref|XP_603315.3), dog (Canis lupus familiaris; gi|374091972, gb|AEY83660.1), rat 
(Rattus norvegicus; gi|194474062, ref|NP_001124037.1), mouse (Mos) (Mus musculus; gi|269914118, 
ref|NP_598848.2), chicken (Chk) (Gallus gallus; gi|118087467, ref|XP_423955.2), frog (Xep) (Xenopus 
tropicalis; gi|301629161, ref|XP_002943716.1), and zebrafish (Zef) (Danio rerio; gi|113682418, 
ref|NP_001038555.1). 
 
we aim to define the functions of FAM83H in cellular and molecular levels, and to unravel the 
potential pathological mechanism of ADHCAI by means of biochemical approaches. Through 
characterizing protein-protein interactome of FAM83H and defining the intracellular localization 
of wild-type and mutant FAM83H proteins, we hope to know what cellular processes FAM83H 




In many pathological conditions, a mutant protein can exert a dominant negative effect by 
interacting with its wild-type protein and lead to a loss of function. With the suspicion that the 
reported FAM83H mutations lead to a dominant negative effect in the pathogenesis of its related 
enamel defects, we hypothesized that FAM83H might interact with itself to form dimers or 
multimers. Furthermore, the N-terminus of FAM83H contains a phospholipase D (PLD)-like 
domain (cd09188) with a predicted structure similar to that of PLD. Since PLD has been shown 
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to form dimers (Stuckey and Dixon, 1999), it is possible that FAM83H can dimerize through its 
N-terminal PLD-like domain. 
In order to test this hypothesis, we first co-expressed Flag-tagged FAM83H and Myc-
tagged FAM83H in HEK293 cells and performed anti-Flag pull-down assays using cell lysates. 
By immunoblotting with anti-Myc tag antibody, we demonstrated that Flag-tagged FAM83H 
could pull down Myc-tagged FAM83H, which suggested that FAM83H interacted with itself 
(Fig. 4.2A). We also tested this self-interaction with two truncated FAM83Hs (FAM83H287X, 
FAM83H697X). The results showed that both Flag-tagged FAM83H287X and FAM83H697X were 
able to pull down Myc-tagged FAM83H, indicating that the N-terminus of FAM83H (the first 
287 amino acids) was responsible for the self-interaction (Fig. 4.2B). 
We also performed protein-protein interaction modeling using SPRING ON-LINE, a 
template-based algorithm for protein-protein structure prediction (Guerler et al., 2013). When the 
sequence of the first 287 amino acids of human FAM83H was used as an input, 6 interaction 
models were predicted. The one with the highest confidence score used phospholipase D from S. 
typhimurium as a template (1byrA) (Fig. 4.2C). This result suggested that FAM83H might form 
a dimer through its N-terminal PLD-like domain (the first 287 amino acids of human FAM83H). 
 
FAM83H interactome 
In addition to self (homomeric) interactions, a mutant protein might exert a dominant 
negative effect by competing with its wild-type protein for (heteromeric) interactions with 
another protein that leads to a loss of function. Also, identifying FAM83H binding partners may 




Figure 4.2: FAM83H self-interaction. 
A: Pull-down assay of two different tagged full-length FAM83H proteins. Flag-tagged FAM83H 
and Myc-tagged FAM83H were co-expressed in HEK293 cells, the cell lysate then underwent 
immunoprecipitation (IP) with α-Flag antibody, and the precipitates were fractionated by SDS-
PAGE and stained with Coomassie Brilliant Blue (CBB) (Left) or immunoblotted with α-Flag 
(Middle) and α-Myc (Right) antibodies (Lanes 1). 3 control experiments were included: Flag-
tagged FAM83H expression only (Lanes 2), Myc-tagged FAM83H expression only (Lanes 3), 
and empty vector expression (Lanes 4). The α-Flag IP pulls down not only Flag-tagged but also 
Myc-tagged FAM83H (~130 kDa bands), suggesting that FAM83H interacts with itself. The ~50 
kDa bands on western blots (WB) are signals from heavy chain of rabbit IgG used for α-Flag IP. 
B: Pull-down assay of C-terminal truncated FAM83H proteins. Myc-tagged full-length 
FAM83H and one of the Flag-tagged FAM83H proteins with various length (WT: full-length; 
287X: a.a.1-287; 697X: a.a.1-697; –: Flag tag only) were expressed and α-Flag 
immunoprecipitated. The IP products as well as initial cell lysates (CL) were blotted with α-Flag 
(Top) and α-Myc (Bottom) antibodies. All 3 different-length FAM83Hs (Flag-tagged) can pull 
down full-length FAM83H (Myc-tagged), suggesting that the first 287 amino acids of the protein 
are sufficient for FAM83H self-interaction. Bands of ~140 kDa, ~36 kDa, and ~75 kDa are full-
length FAM83H, FAM83H287X, and FAM83H697X respectively. 
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C: Predicted human FAM83H287X dimerization model. The interaction model was predicted by 
SPRING ON-LINE software (Guerler et al., 2013). The first 287 amino acids of human 
FAM83H was used as an input, and the structure of phospholipase D from S. typhimurium 
(1byrA) was used as a modeling template. The F270-X-X-X-F274-X-X-X-F278 motif is located at 
the red α-helix. Left: Side view. Right: Top view. 
 
proteins using affinity purification combined with mass-spectrometry (AP-MS) (Gingras et al., 
2007; Dunham et al., 2012). We over-expressed Flag-tagged mouse FAM83H in HEK293 cells 
and performed immunoprecipitation with anti-Flag antibody. The immunoprecipitates were then 
resolved by SDS-PAGE, and 6 specific bands on the gel were sliced out and submitted for 
protein identification by mass-spectrometry. By this means, all of the proteins that co-
immunoprecipitated with the affinity-purified FAM83H would be identified, and the potential 
binding partners of FAM83H could be determined by subsequent analyses. A total of 143 
proteins were identified by mass spectrometry, including 89 matches with a high confidence 
score (p<0.05). The identified potential interacting proteins were involved in various cellular 
processes (Tab. 4.1). 
 
Table 4.1: Potential FAM83H interacting proteins. 
Over-expressed Flag-tagged mouse FAM83H protein (in HEK293 cells) underwent affinity purification 
followed by mass spectrometry (AP-MS) to identify potential binding partners of FAM83H. Only human 
proteins identified with a significant Mascot score (≥ 85 in this case) are listed. Note that endogenous 
human FAM83H protein can be co-immunoprecipitated by over-expressed mouse FAM83H protein, 














reticulocalbin 1, EF-hand 
calcium binding domain 
ACTG1 actin, gamma 1 HNRNPC 
heterogeneous nuclear 
ribonucleoprotein C (C1/C2) 
RCN2 
reticulocalbin 2, EF-hand 
calcium binding domain 
ACTR2 
ARP2 actin-related protein 2 
homolog (yeast) 
HSPA1A heat shock 70kDa protein 1A RFC3 
replication factor C 
(activator 1) 3, 38kDa 
ARF4 ADP-ribosylation factor 4 HSPA9 
heat shock 70kDa protein 9 
(mortalin) 




ATPase family, AAA 
domain containing 3A 
IGF2BP1 
insulin-like growth factor 2 
mRNA binding protein 1 
RPL27 ribosomal protein L27 
ATAD3B 
ATPase family, AAA 
domain containing 3B 
KRT1 keratin 1 RPL28 ribosomal protein L28 
CAD 
carbamoyl-phosphate 
synthetase 2, aspartate 
transcarbamylase, and 
dihydroorotase 
KRT10 keratin 10 RPLP0 ribosomal protein, large, P0 
CALU calumenin KRT2 keratin 2 RPS13 ribosomal protein S13 
CAPZA1 
capping protein (actin 
filament) muscle Z-line, 
alpha 1 





myosin, heavy chain 10, 
non-muscle 
RPS19 ribosomal protein S19 
CNOT1 
CCR4-NOT transcription 
complex, subunit 1 
MYH14 myosin, heavy chain 14 RPS20 ribosomal protein S20 
CSNK1A1 casein kinase 1, alpha 1 MYH9 
myosin, heavy chain 9, non-
muscle 
RPS25 ribosomal protein S25 
CSNK1E casein kinase 1, epsilon MYL6 
myosin, light chain 6, alkali, 
smooth muscle and non-
muscle 
SEC16A 




box polypeptide 3, X-linked 
NES nestin SLC25A13 
solute carrier family 25, 
member 13 (citrin) 
DNAJB2 
DnaJ (Hsp40) homolog, 










DnaJ (Hsp40) homolog, 
subfamily B, member 6 





family with sequence 
similarity 83, member H 
PPP1CA 
protein phosphatase 1, 
catalytic subunit, alpha 
isoform 
TIMM50 
translocase of inner 
mitochondrial membrane 50 





RNA binding motif protein 
14 
TOMM22 
translocase of outer 
mitochondrial membrane 22 
homolog (yeast) 
HELZ helicase with zinc finger RBM4 RNA binding motif protein 4 TRAFD1 
TRAF-type zinc finger 
domain containing 1 
 
 
FAM83H and casein kinase 1 interaction 
 Based upon the AP-MS results, several members of casein kinase 1 (CK1) family could 
be identified in the immunoprecipitates of Flag-tagged FAM83H (FAM83H-Flag). In order to 
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validate this interaction, co-immunoprecipitation of endogenous CK1δ, and CK1ε (CSNK1D and 
CSNK1E) with over-expressed FAM83H-Flag in HEK293 cells was performed. The results 
showed that FAM83H-Flag could precipitate CK1δ, and CK1ε by Flag antibody 
immunoprecipitation, while the control-Flag could not, which demonstrated the specificity of the 
FAM83H-CK1 interaction (Fig. 4.3A). 
Searching for potential CK1 binding sites, Okamura et al. identified a conserved docking 
motif for CK1 binding (F-X-X-X-F) in many of the CK1-interacting proteins (Okamura et al., 
2004). Interestingly, in human FAM83H, there are four of such a sequence motif in its N-
terminus (F247-X-X-X-F251; F270-X-X-X-F274; F274-X-X-X-F278; F350-X-X-X-F354) (Fig. 4.1B), 
with the first three being highly conserved among the FAM83H orthologs during vertebrate 
evolution. The F270-X-X-X-F274-X-X-X-F278 motif is particularly conserved among the human 
FAM83 paralogs, suggesting that this motif might be a potential CK1 binding site in FAM83H. 
Noticeably, this motif is located at a highly-conserved sequence area right before Ser287 of 
FAM83H, which corresponds to the most N-terminal FAM83H truncation mutation reported so 
far (Fig. 4.1B). Therefore, we hypothesized that FAM83H interacts with CK1 through its F270-X-
X-X-F274-X-X-X-F278 motif, and that all of the disease-causing truncation FAM83H, including 
the shortest and the longest one, can interact with CK1. 
In order to test this hypothesis, two constructs expressing truncated mouse FAM83H with 
N-terminal Flag tag (FAM83H287X, FAM83H697X) were generated, and their ability to interact 
with CK1 was tested. FAM83H287X corresponded to the shortest disease-causing FAM83H 
truncation and FAM83H697X the longest. HEK293 cells were transfected with constructs 
expressing Myc-tagged CK1ε and one of the Flag-tagged FAM83Hs with various lengths (WT, 




Figure 4.3: FAM83H-CK1 interaction. 
A: Co-immunoprecipitation of FAM83H and CK1. Flag-tagged FAM83H was expressed in HEK293 
cells, and cell lysates underwent α-Flag immunoprecipitation (IP). The IP products and initial cell 
lysates (CL) were fractionated and immunoblotted with α-Flag (Left), α-CK1δ (Middle), and α-CK1ε 
(Right) antibodies. Bands of ~130 kDa, ~49 kDa, and ~47 kDa are FAM83H, CK1δ, and CK1ε 
respectively. Flag-tagged FAM83H, but not control, IP can precipitate endogenous CK1δ and CK1ε, 
confirming the results from our AP-MS experiments. 
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B: Pull-down assay of C-terminal truncated FAM83H proteins. Myc-tagged CK1 and one of the Flag-
tagged FAM83H proteins with various length (WT: full-length; 287X: a.a.1-287; 697X: a.a.1-697; –: 
Flag tag only) were expressed and α-Flag immunoprecipitated. The IP products as well as initial cell 
lysates (CL) were blotted with α-Flag (Top) and α-Myc (Bottom) antibodies. All 3 different-length 
FAM83Hs (Flag-tagged) can pull down CK1 (Myc-tagged), suggesting that the first 287 amino acids 
of the protein are sufficient for FAM83H-CK1 interaction. Bands of ~140 kDa, ~36 kDa, and ~75 kDa 
are full-length FAM83H, FAM83H287X, and FAM83H697X respectively. 
C: Pull-down assay of N-terminal truncated FAM83H proteins. Similar pull-down assays were performed 
with two different Flag-tagged FAM83H proteins without N-terminus (288C: a.a.288-1209; 698X: 
a.a.698-1209). While FAM83H287X (Flag-tagged) can pull down CK1 (Myc-tagged), neither 
FAM83H288C nor FAM83H698C can, confirming that the first 287 amino acids of the protein are 
necessary for FAM83H-CK1 interaction. Top: Bands of ~110 kDa and ~65 kDa are FAM83H288C and 
FAM83H698C respectively. Bottom: CK1 is ~50 kDa. 
D: Pull-down assay of FAM83H proteins with site-directed mutagenesis. Similar pull-down assays were 
performed with a Flag-tagged FAM83H in which F270, F274, and 278 are substituted with Alanines (3FA: 
F270-X-X-X-F274-X-X-X-F278 to A270-X-X-X-A274-X-X-X-A278). Compared to wild-type (WT) 
FAM83H, FAM83H3FA has significantly reduced ability to pull down CK1, suggesting the F270-X-X-
X-F274-X-X-X-F278 motif is critical for FAM83H-CK1 interaction. 
 
underwent immunoprecipitation with Flag antibody, and the immunoprecipitates were blotted 
with anti-CK1ε antibody (or anti-Myc tag antibody). As shown on the immunoblot, all three of 
the variable-length FAM83H truncations, but not the empty vector control, could pull down 
over-expressed CK1ε, meaning that the first 287 amino acids of FAM83H are sufficient to 
interact with CK1ε (Fig. 4.3B). We also tested the CK1-binding ability of two N-terminal 
truncated FAM83Hs (FAM83H288-1209, FAM83H698-1209) and showed that neither of these 
truncated proteins could pull down CK1ε, further demonstrating that the N-terminus (amino 
acids 1-287) of FAM83H is necessary and sufficient for FAM83H-CK1 interaction (Fig. 4.3C). 
We mutagenized the three phenylalanines (F270, F274, F278), potentially serving as a CK1 
docking site in FAM83H, to alanines (FAM83H3FA) by site-directed mutagenesis and evaluated 
this motif for its importance in CK1 binding. By using the same pull-down assays, we 
demonstrated that site-directed mutagenesis of F270, F274, F278 to A270, A274, A278 in FAM83H 
significantly attenuated its ability to interact with CK1ε (Fig. 4.3D). This result supported our 
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hypothesis that FAM83H interacts with CK1 through its F270-X-X-X-F274-X-X-X-F278 motif in 
N-terminus. 
 
Mouse recombinant FAM83H phosphorylation by casein kinase 1 in vitro 
The FAM83H-CK1 interaction raises the possibility that FAM83H might be 
phosphorylated by CK1, since there are many predicted CK1 phosphylation sites with a specific 
D/E/pS-X-X-Ser/Thr motif in FAM83H. In order to test if FAM83H is the substrate of CK1, we 
used bacterial-expressed mouse recombinant FAM83H and performed an in vitro kinase assay. 
Incubated with γ-33P-ATP, the recombinant FAM83H showed much stronger radioactivity when 
CK1 was added, compared with a CK2 (casein kinase 2) and no kinase control, which 
demonstrated that FAM83H can be phosphorylated by CK1 in vitro (Fig. 4.4). The kinase assays 
were mainly conducted by Drs. Jan Hu and Yasuo Yamakoshi. 
We submitted the CK1-phosphorylated mouse recombinant FAM83H (with cold ATP) 
for mass-spectrometry to identify the exact CK1 phosphorylation sites in FAM83H. The results 
showed that most of the CK1-phosphorylated Serines and Threonines were located at the C-
terminus of FAM83H (Fig. 4.4). 
 
FAM83H and SEC16A interaction 
Previously, our group showed that over-expressed GFP-tagged mouse FAM83H partly 
localized in the trans-Golgi network of HEK293 cells, which suggested that FAM83H might be a 




Figure 4.4: FAM83H phosphorylation by CK1 in vitro. 
Left: Autoradiograph of 33P kinase assay. Purified mouse recombinant FAM83H proteins were incubated 
with CK1, CK2, or no enzyme (–) as well as radioactive 33P-ATP at 30˚C for 60 min. The reaction 
samples were fractionated with SDS-PAGE, and the dried gel was exposed to a film. The CK1 reaction 
shows strong radioactivity at a specific band of ~130 kDa, demonstrating that CK1 can phosphorylate 
FAM83H in vitro. (The autoradiograph is courtesy for Drs. Jan Hu and Yasuo Yamakoshi.) Right: CK1 
phosphorylation sites on FAM83H. The phosphorylation sites are determined by mass spectrometry of 
CK1-treated mouse FAM83H protein. The CK1-phosphorylated Serines and Threonines, which mainly 
locate at C-terminus of FAM83H, are marked red/bold. 
 
Searching for protein candidates involved in membrane trafficking in our AP-MS data of 
FAM83H, we identified another potential FAM83H-binding protein, SEC16A, which might 
imply the function of FAM83H (Tab. 4.1). SEC16A is a protein that forms part of the COP II 
complex, which mediates vesicle formation and protein transport from endoplasmic reticulum 
(ER) to Golgi (Iinuma et al., 2007; Miller and Barlowe, 2010; Zanetti et al., 2012). SEC16A 
localized to the ER exit site (transitional ER), close to the Golgi, where GFP-tagged FAM83H 
had localized. 
In order to validate this FAM83H-SEC16A interaction, we performed the same pull-
down assays as we did for the FAM83H-CK1 interaction. Different-length Flag-tagged 
FAM83Hs (WT, FAM83H287X, FAM83H697X, and empty vector control) were tested for their 
ability to bind over-expressed Halo-tagged SEC16A. As shown on anti-SEC16A (as well as anti-
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Halo tag) immunoblot, while full-length (WT) FAM83H and FAM83H697X could pull down 
Halo-tagged SEC16A, FAM83H287X could not, suggesting that FAM83H interacted with 
SEC16A and the middle part of the protein (amino acids 287-697 of mouse FAM83H) might be 
important for this interaction (Fig. 4.5A). This result was further validated by no interaction 
between Flag-tagged full-length FAM83H and control HaloTag® protein (~300 amino acids), 
which demonstrated the specificity of FAM83H-SEC16A interaction (Fig. 4.5B). 
Previously, Lee et al. expressed different truncated GFP-tagged human FAM83Hs (WT, 
FAM83H325X, FAM83H460X, FAM83H677X, FAM83H694X) in HEK293 cells and showed altered 
intracellular localization of these truncated proteins (Lee et al., 2011). In their results, while full-
length (WT) FAM83H and FAM83H697X localized to the cytoplasm, all of the other truncated 
proteins (FAM83H325X, FAM83H460X, FAM83H677X) localized to the nucleus, which suggested 
that the area between amino acid 677 and 694 might be important for FAM83H to stay at its 
physiological location (cytoplasm). Correspondingly, there is a highly conserved sequence area 
in amino acids 664-688 of human FAM83H, which implies it has functional significance (Fig. 
4.1C). Therefore, with our previous result showing that amino acids 287-697 of mouse FAM83H 
are important for SEC16A binding, we hypothesized that the conserved domain in the middle of 
FAM83H (amino acids 664-688 of human FAM83H) might serve as a SEC16A binding site and 
keep FAM83H at its physiological location. 
To test this hypothesis, in addition to FAM83H697X, we generated another construct, 
FAM83H657X, to express a shorter form of truncated mouse FAM83H in which the conserved 
domain was deleted. With similar pull-down assays, we tested the SEC16A-binding ability of 




Figure 4.5: FAM83H-SEC16A interaction. 
A: Pull-down assay of C-terminal truncated FAM83H proteins. Halo-tagged SEC16A and one of the 
Flag-tagged FAM83H proteins with various length (WT: full-length; 287X: a.a.1-287; 697X: a.a.1-
697; –: Flag tag only) were expressed and α-Flag immunoprecipitated. The IP products as well as 
initial cell lysates (CL) were blotted with α-Flag (Top) and α-HaloTag® (Bottom) antibodies. While 
full-length FAM83H and FAM83H697X (Flag-tagged) can pull down SEC16A (Halo-tagged), 
FAM83H287X cannot, suggesting that the middle part of FAM83H (a.a.287-697) may be responsible for 
interacting with SEC16A. Bands of ~140 kDa, ~36 kDa, and ~75 kDa are full-length FAM83H, 
FAM83H287X, and FAM83H697X respectively. 
B: Pull-down assay of FAM83H and control HaloTag® protein. Similar pull-down assays were 
performed with control HaloTag® protein (HaloTag® is ~300 amino acid long). Full-length FAM83H 
(Flag-tagged) can pull down SEC16A (Halo-tagged), but not HaloTag® protein, demonstrating the 
specificity of FAM83H-SEC16A interaction; the interaction is not through HaloTag®.  Top: Bands of 
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~140 kDa, ~36 kDa, and ~75 kDa are full-length FAM83H, FAM83H287X, and FAM83H697X 
respectively. Bottom: SEC16A-Halo is ~270 kDa, and control HaloTag® protein is ~30 kDa. 
C: Pull-down assay of FAM83H657X. Similar pull-down assays were performed with another C-terminal 
truncated FAM83H (657X: a.a.1-657). Both FAM83H657X and FAM83H697X (Flag-tagged) can pull 
down SEC16A (Halo-tagged), suggesting that the region between amino acid 657 and 697 may not be 
necessary for FAM83H-SEC16A interaction. The ~70 kDa band is FAM83H657X. 
 
FAM83H287X did not show interaction with SEC16A, both FAM83H657X and FAM83H697X were 
able to pull down Halo-tagged SEC16A, which suggested that amino acids 657-697 of mouse 
FAM83H (including the conserved domain) might not be critical for SEC16A binding (Fig. 
4.5C). 
We also performed immunostaining with anti-Flag antibody in HEK293 cells over-
expressing Flag-tagged full-length FAM83H and FAM83H697X. Unexpectedly, while full-length 
FAM83H showed localization in the cytoplasm, the FAM83H697X localized in the nucleus, which 
is inconsistent with the results from previous report (Lee et al., 2011). However, interestingly, 
we observed altered intracellular localization of endogenous CK1ε in HEK293 cells over-
expressing FAM83H697X. While CK1ε showed a diffuse cytoplasmic localization pattern when 
full-length FAM83H was over-expressed, in the presence of FAM83H697X, CK1ε localized to the 
nucleus as FAM83H697X itself did (Fig. 4.6). 
 
DISCUSSION 
FAM83H is the first AI candidate gene identified to encode a non-secretory, non-enamel-
matrix protein. Human mutational studies are so far the only evidence indicating the 
physiological function of FAM83H, but the molecular function and the pathological mechanism 
of its associated enamel malformations are completely unknown. To date, all of the reported 




Figure 4.6: FAM83H and CK1E immunocytochemistry. 
Flag-tagged full-length (WT) and truncated (697X) FAM83H proteins were expressed in HEK293 cells, 
and immunostained with α-Flag (green) and α-CK1E (red) antibodies. Top: Both over-expressed WT 
FAM83H (green) and endogenous CK1E (red) localize at cytoplasm. Bottom: Unlike WT FAM83H, 
over-expressed FAM83H697X (green) localizes at nucleus, which endogenous CK1E (red) is also mis-
localized to. The most right panels are the superimposition of Flag and CK1E images. Blue: DAPI 
nuclear staining. 
 
287 and 694 in human FAM83H protein (Fig. 1.4). All of the mutations are expected to produce 
a mutant truncated protein. This genetic homogeneity of human FAM83H mutational spectrum 
not only suggests a dominant negative effect as a pathological mechanism but also provides 
valuable genetic information about the potential functional domains of this protein. 
In this study, we demonstrate that FAM83H interacts with itself and probably dimerizes 
through interactions within its first 287 amino acids (the predicted PLD-like domain). This 
finding suggests that, under pathological conditions, the mutant truncated protein can interact 
with the wild-type protein and prevent it from functioning, which supports the dominant negative 
effect we proposed. Self-interactions in the N-terminal domain (1-287 amino acids) also provides 
a plausible explanation for why there are no reported disease-causing mutations N-terminal to 
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Ser287. It is possible that the C-terminus of FAM83H may be the actual functional domain of this 
protein, while dimerization through the N-terminus may be critical for the protein to execute its 
function. Therefore, truncated proteins produced by disease-causing FAM83H mutations (from 
FAM83H287X to FAM83H694X) can still interact with the full-length FAM83H protein expressed 
from the wild-type allele, but the truncation-wild type protein complex fails to function. In 
contrast, any truncated FAM83H protein without a functional dimerization domain (shorter than 
FAM83H287X) cannot bind to the wild-type protein. Half the normal number of wild-type dimers 
form so no disease phenotype is observed. However, further research needs to be conducted to 
demonstrate this hypothesis. 
In addition to FAM83H self-interactions, we also demonstrated that FAM83H can 
interact with CK1 and the first 287 amino acids of FAM83H are necessary and sufficient for this 
interaction. A specific sequence motif, F270-X-X-X-F274-X-X-X-F278, located at an evolutionarily 
conserved region N-terminal to Ser287, seems to play a critical role in the FAM83H-CK1 
interaction. This finding is further supported by a study of the CK1 interactome (Kategaya et al., 
2012) and a study about FAM83H in colorectal cancer (Kuga et al., 2013). Furthermore, we 
showed that FAM83H interacts with SEC16A, a protein component of the COP II complex that 
is critical for ER-to-Golgi membrane trafficking, and that this interaction may be mediated by a 
domain in the middle of FAM83H (amino acids 287-657 in mouse). Along with a recent 
interesting finding that CK1 kinase activity is critical for vesicle trafficking between ER and 
Golgi (Lord et al., 2011), our results provide an incomplete, but plausible pathological 
mechanism for FAM83H-associated AI. 
It is known that the subcellular localization of CK1 is an important factor in its functional 
regulation (Knippschild et al., 2005). Therefore, our finding that FAM83H interacts with CK1 
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and SEC16A via distinct domains suggest that FAM83H may function as a scaffold protein to 
bring CK1 to the place where SEC16A localizes, the ER exit site, so that CK1 can facilitate 
vesicle trafficking between ER and Golgi. If this hypothesis were true, all of the disease-causing 
FAM83H mutations (from FAM83H287X to FAM83H694X) would produce a truncated protein that 
is able to bind to CK1 through its N-terminus, but fails to localize to the ER exit site due to the 
absence of the SEC16A-interacting domain. In other words, the mutant truncated FAM83H 
would compete with wild-type FAM83H for binding to and correctly localizing CK1, causing the 
dominant negative effect. Our finding that over-expression of mouse FAM83H697X leads to 
aberrant subcellular localization of CK1 supports this hypothesis. 
This proposed mechanism also provides a plausible explanation for why there are no 
reported disease-causing mutations N-terminal to Ser287 or C-terminal to Glu694. While a 
truncated protein shorter than FAM83H287X lacks CK1-interacting domain and loses the ability to 
compete for CK1 binding so no dominant negative effect, a truncated protein longer than 
FAM83H694X contains both CK1- and SEC16A-binding domains and is functionally sufficient to 
localize CK1 to the ER exit site. In both scenarios, the function of wild-type FAM83H would not 
be disturbed, so no pathology is observed. Instead, only truncated proteins with specific lengths 
(from FAM83H287X to FAM83H694X) that can bind to CK1 but not SEC16A would be disease-
causing. 
Based upon our proposed mechanism, we hypothesized that an evolutionarily-conserved 
sequence area immediately N-terminal to Glu694 of FAM83H might be responsible for interacting 
with SEC16A, so that a truncated protein shorter than human FAM83H694X cannot bind to 
SEC16A, causing pathology. However, a truncated FAM83H without this conserved region 
(mouse FAM83H657X) appeared to be sufficient for SEC16A binding, suggesting that this region 
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is not necessary for the FAM83H-SEC16A interaction. Moreover, if our proposed mechanism 
were true, any truncated FAM83H longer than human FAM83H694X should be able to co-
localize, at least partly, with SEC16A. Nevertheless, mouse FAM83H697X, which contains the 
conserved region, showed aberrant localization to nucleus when over-expressed in HEK293 
cells. 
These unexpected results seemed to disprove our proposed pathological mechanism. 
However, there are several alternative explanations. First of all, we picked SEC16A for further 
investigation based upon our previous observation that over-expressed GFP-tagged FAM83H 
localized to the Golgi, which suggested that FAM83H might be involved in vesicle trafficking. 
However, the selection of potential FAM83H-interacting proteins for further study was arbitrary. 
It is possible that our hypothesis that FAM83H functions as a scaffold protein to bring CK1 to 
specific subcellular localizations might be still correct, but the localization is not through 
SEC16A. Recently, Kuga et al. reported that FAM83H interacted with cytokeratin and was 
associated with cytoskeletal organization (Kuga et al., 2013), although we could not successfully 
reproduce the results with our experimental system (data not shown). Therefore, we may need to 
revisit FAM83H AP-MS data and test other plausible FAM83H-interacting proteins (including 
cytokeratins expressed by ameloblasts) to better assess the specific roles of FAM83H in cells. 
Inconsistent with what was reported by Lee et al. (Lee et al., 2011), our 
immunocytostaining showed nuclear localization of mouse FAM83H697X. This discrepancy of 
protein localization might be due to artifacts from different protein-tag systems (GFP v.s. Flag) 
or because the FAM83H protein was from different species (human v.s. mouse). Also, in some 
cases, subcellular localization of proteins can be affected by cell-line differences and levels of 
protein over-expression. Therefore, our proposed mechanism that the truncated FAM83H longer 
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than human FAM83H694X is able to correctly localize CK1 and is not disease-causing might still 
be valid. In order to demonstrate this molecular mechanism, in the future, we may consider using 
human FAM83H protein and ameloblast-like cell lines (or primary ameloblast culture) for in 
vitro protein localization experiments. Ideally, mouse models expressing different truncated 
FAM83H proteins would be the most physiologically relevant system for determining the 
localizations of mutant proteins in ameloblasts and for testing our proposed pathological 
mechanism, although such studies may not be cost-effective. 
In this study, we also showed that recombinant mouse FAM83H can be phosphorylated 
by CK1 in vitro, and most of the phosphorylation sites are located in the C-terminus of 
FAM83H, although most of these phosphorylated Serines and Threonines are not evolutionarily 
conserved. Therefore, at this stage, we are not sure if FAM83H phosphorylation by CK1 is 
functionally or structurally significant. However, interestingly, there are two amino acid 
sequence areas (1025-1055, 1114-1139 in human FAM83H) at the C-terminus of FAM83H that 
show high sequence conservation during vertebrate evolution (Fig. 4.1E), suggesting that these 
regions may be important for FAM83H function. Given that FAM83H is a scaffold protein as we 
suspect, these two sequence areas may serve as protein docking sites. Using additional truncated 
FAM83H proteins to define the functions of these conserved domains seems to be the next 
logical pursuit. 
In summary, by means of biochemical and molecular characterization, we showed here 
that FAM83H interacts with itself, CK1, and SEC16A through distinct domains, which suggests 
that FAM83H may serve as a scaffold protein for protein complex assembly. Based upon the 
protein-binding domains of FAM83H we defined as well as results from human mutational 
studies, we proposed a potential function for FAM83H that this protein is responsible for 
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correctly localizing CK1 to a specific subcellular domain and a pathological mechanism for 
FAM83H-associated AI that the disease phenotype comes from aberrant CK1 localization 
mediated by truncated FAM83H with specific lengths. Further investigations need to be 
conducted to test these hypotheses. 
 
MATERIALS AND MATHODS 
Expression constructs 
Mouse Fam83h cDNA was cloned into phrGFP-C vector by Dr. Yumei Ding (Ding et al., 
2009). The Fam83h coding region from phrGFP-C-Fam83h was excised by double digestion 
with NotI and SalI, and subcloned into pCMV-Tag4A and pCMV-Tag5A vectors (211174, 
211175; Agilent Technologies; Santa Clara, CA, U.S.A.) to express C-terminal Flag-tagged and 
Myc-tagged mouse FAM83H. These two constructs were used for FAM83H self-interaction 
experiments. The pCMV-Tag4A-Fam83h was also used to over-express Flag-tagged FAM83H 
for affinity purification-mass spectrometry (AP-MS) experiment. 
Seven constructs to express different domains, truncations, and mutations of FAM83H 
protein were generated by Custom DNA Constructs, LLC (Cleveland, OH, U.S.A.). They are 
pCMV-Tag2B-Fam83h, pCMV-Tag2B-Fam83h287X, pCMV-Tag2B-Fam83h657X, pCMV-Tag2B-
Fam83h697X, pCMV-Tag2B-Fam83h288C, pCMV-Tag2B-Fam83h698C, and pCMV-Tag2B-
Fam83h3FA. The pCMV-Tag2B-Fam83h construct encodes a full-length mouse FAM83H protein 
(1209 amino acids). The pCMV-Tag2B-Fam83h287X, pCMV-Tag2B-Fam83h657X, and pCMV-
Tag2B-Fam83h697X constructs were made by introducing three respective premature stop codons 
into pCMV-Tag2B-Fam83h construct to express three truncated FAM83H proteins (1-287, 1-
657, and 1-697 amino acids). The pCMV-Tag2B-Fam83h288C and pCMV-Tag2B-Fam83h698C 
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constructs were designed to express two different-length C-terminal domain of FAM83H protein 
(288-1209 and 698-1209 amino acids). The pCMV-Tag2B-Fam83h3FA construct was generated 
by introducing three site-directed mutations into pCMV-Tag2B-Fam83h, which encodes a full-
length FAM83H protein with three Phenylalanine-to-Alanine substitutions (p.Phe270Ala, 
p.Phe274Ala, and p.Phe278Ala). All the encoded FAM83H proteins contain an N-terminal Flag 
tag. These six constructs were used for protein pull-down assays to study FAM83H protein-
protein interaction. 
Constructs expressing 6xMyc-tagged CK1δ and CK1ε (pcDNA3-CK1δ-6xMyc, 
pcDNA3-CK1ε-6xMyc) were gifts from Dr. Ying-Hui Fu (University of California San 
Francisco) (Kategaya et al., 2012). The construct expressing Halo-tagged human SEC16A 
(FHC00048) and the HaloTag® control vector (G6591) were purchased from Promega 
Corporation (Madison, WI, U.S.A.). 
 
Cell culture and plasmid transfection 
Human HEK293 cells were cultured in Dulbeccos modified Eagle medium (DMED) 
(11995; Gibco® by Life Technologies; Grand Island, NY, U.S.A.) with 10% (v/v) fetal bovine 
serum (FBS) (16000; Gibco® by Life Technologies) in a 5% CO2 humidified culture incubator. 
Cells were regularly passaged when reaching 95-100% confluency. 
For transient plasmid transfection, cells in 2 mL DMEM was plated on 6-well plates the 
day before transfection so that the cell confluency could reach 75-80% on the day of transfection. 
4 μg of plasmid in 10 μL of Lipofectamine® 2000 (11668; InvitrogenTM by Life Technologies) 
was diluted with 500 μL of Opti-MEM® I reduced serum medium (31985; Gibco® by Life 
Technologies), and incubated for 20 min at room temperature. The plasmid/Lipofectamine® 
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2000 complexes were then added to the culture media. After 6 h incubation, the culture media 
were changed to the regular media without transfection complexes, and the cells were further 
cultured for 42 h before harvested. 
 
Immunoprecipitation (IP) 
48 h following transfection, cells were washed twice with cold phosphate-buffered saline 
(PBS) and, for each well of 6-well plates, lysed with 500 μL NP40 cell lysis buffer (FNN0021; 
Novex® by Life Technologies) with 1 mM phenylmethylsulfonyl fluoride (PMSF) (P7626; 
Sigma-Aldrich; St. Louis, MO, U.S.A.) and 1X protease inhibitor cocktail (P2714; Sigma-
Aldrich). After 30 min lysis, the lysates were collected and centrifuged at 15,000 rpm for 10 min. 
The supernatants were then used for subsequent analyses. 
Dynabeads® protein A immunoprecipitation kit (10006D; Novex® by Life 
Technologies) was used for all the immunoprecipitation experiments. The experimental 
procedure followed the protocol provided by the manufacturer. In brief, anti-Flag antibody (1:20; 
F7425; Sigma-Aldrich) was incubated with protein A-attached Dynabeads for 30 min. The 
antibody/Dynabeads complexes were then mixed with the cell lysate and incubated for another 
30 min at room temperature. After washed twice, the immunoprecipitates were eluted and 
assayed for SDS-PAGE and immunoblotting. 
 
SDS-PAGE electrophoresis and Coomassie brilliant blue staining 
Protein samples were prepared with 4X NuPAGE® LDS sample buffer (NP0007; 
Novex® by Life Technologies) in a 1:3 ratio and run on NuPAGE® 4-12% Bis-Tris protein gels 
(NP0322BOX; Novex® by Life Technologies) with NuPAGE® MES SDS running buffer 
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(NP0002; Novex® by Life Technologies). Electrophoresis was performed at a constant voltage 
of 200V for 30-35 min. 
After electrophoresis, the protein gels were washed in distilled water for 3X 5 min, 
stained with SimplyBlueTM SafeStain (LC6065; Novex® by Life Technologies) for 40-60 min, 
and de-stained in distilled water for several hours. 
 
Western blot analysis 
After SDS-PAGE, the proteins on the gel were transblotted onto a nitrocellulose 
membrane (LC2000; Novex® by Life Technologies) with NuPAGE® transfer buffer (NP0006; 
Novex® by Life Technologies) at a constant voltage of 30V for 70-100 min. The membrane was 
subsequently blocked with 5% non-fat milk (170-6404XTU; Bio-Rad Laboratories; Hercules, 
CA, U.S.A.) in TBS-Tween (20 mM Tris, 500mM NaCl, 0.1% Tween-20, pH 7.5) for 1 h, and 
incubated with primary antibody for 2 h at room temperature or overnight at 4˚C. After washed 
with TBS-Tween for 3X 10 min, the membrane was incubated with HRP-conjugated secondary 
antibody for 1 h and then washed for 3X 20 min. Blots were immersed with chemiluminescence 
ECL western blotting detection reagent (RPN2232; GE Healthcare; Little Chalfont, U.K.) for 5 
min and exposed to a film. 
Primary antibodies used for western blot analysis include: anti-FLAG® (F7425) 
(1:2000), anti-FLAG® M2 (F1804) (1:4000), anti-c-Myc (C3956) (1:2000) from Sigma-Aldrich 
(St. Louis, MO, U.S.A.); anti-Myc Tag, clone 4A6 (05-724) (1:4000) from Millipore 
Corporation (Billerica, MA, U.S.A.); anti- CK1α1 [EPR1961(2)] (ab108296) (1:2000), anti-
CK1δ [AF12G4] (ab85320) (1:4000), anti-CK1ε [AF6C1] (ab82426) (1:2000), anti-SEC16A 
(ab70722) (1:2000) from abcam® (Cambridge, MA, U.S.A.); anti-HaloTag® (G9211) (1:1000) 
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from Promega Corporation (Madison, WI, U.S.A.). Two secondary antibodies were used: ECL 
anti-rabbit IgG (NA934V; GE Healthcare; Little Chalfont, U.K.) and anti-mouse IgG+IgM HRP 
(ab47827; abcam®; Cambridge, MA, U.S.A.). 
 
Protein-protein interaction modeling 
SPRING ON-LINE (http://zhanglab.ccmb.med.umich.edu/spring/) (Guerler et al., 2013) 
from Zhang laboratory at University of Michigan was used for modeling potential FAM83H 
dimerization. Sequence of the first 287 amino acids (PLD-like domain) from human FAM83H 
protein was used for both query sequence A and query sequence B. 
 
Affinity purification combined with mass spectrometry (AP-MS) 
Flag-tagged mouse FAM83H protein was over-expressed by transiently-transfected 
HEK293 cells on a 10-cm Petri dish. The cell lysate from all the harvested cells underwent 
immunoprecipitation (with anti-FLAG® antibody), and the immunoprecipitate was further 
fractionated with SDS-PAGE, as described in the above sections. After Coomassie brilliant blue 
staining, 6 specific protein bands were sliced out and submitted to Keck Biotechnology Resource 
Laboratory at Yale University, where trypsinization, LC-MS/MS mass spectrometry for protein 
identification, and subsequent data analysis were performed. 
 
In vitro kinase reaction 
For each kinase reaction, 0.2 mg purified mouse recombinant FAM83H was incubated 
with 5000 units of casein kinase 1 (P6030S), casein kinase 2 (P6010S; New England BioLabs®; 
Ipswich, MA, U.S.A.), or no enzyme and 0.05µCi 33P-ATP in a total reaction volume of 20 μL. 
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The reactions were conducted at 30˚C for 60 min and subsequently fractionated with SDS-PAGE 
of Novex® 4-20% Tris-Glycine protein gels (EC60255BOX; Novex® by Life Technologies). 
After drying, the gel was exposed to a film for 20 min. The kinase assays were mainly conducted 
by Drs. Jan Hu and Yasuo Yamakoshi. 
For determination of CK1 phosphorylation sites on FAM83H protein, mass spectrometry 
was used. The kinase reaction was conducted using above-mentioned method except that non-
radioactive cold ATP was used. The reaction was fractionated with SDS-PAGE. After 
Coomassie brilliant blue staining, the band of FAM83H was sliced out and submitted to Keck 
Biotechnology Resource Laboratory at Yale University, where trypsinization, LC-MS/MS mass 
spectrometry for protein post-translational modification identification, and subsequent data 
analysis were performed. 
 
Immunocytochemistry (ICC) 
HEK293 cells were cultured in Lab-Tek chamber slides (1 chamber) with cover (70360-
12; Electron Microscopy Sciences; Hatfield, PA, U.S.A.) and transfected with pCMV-Tag2B-
Fam83h, pCMV-Tag2B-Fam83h697X, or control empty vector. After 18 h, the cells were fixed 
with 100% methanol for 15 min at -20˚C, washed with PBS buffer for 3 times. Following 
blocking with 5% sheep serum (S22; Millipore Corporation; Billerica, MA, U.S.A.) in PBT 
buffer (0.1% Triton X-100 in PBS buffer) for 30 min at room temperature, anti-FLAG® antibody 
(1:200; F7425; Sigma-Aldrich; St. Louis, MO, U.S.A.) and anti-CK1ε antibody (1:200; ab82426; 
abcam®; Cambridge, MA, U.S.A.) were applied. After overnight incubation of primary antibody 
at 4˚C, the cells were washed with PBS buffer for 15 min and then incubated for 30 min at room 
temperature in solutions containing anti-rabbit IgG secondary antibody conjugated with Alexa 
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Fluor 488 (1:500; A-11008; Molecular Probes® by Life Technologies) and anti-mouse IgG1 
secondary antibody conjugated with Alexa Fluor 594 (1:500; A-21125; Molecular Probes® by 
Life Technologies). The slides were then rinsed in PBS buffer for 15 min, mounted with 
ProLong® Gold antifade reagent with DAPI (P-36941; Molecular Probes® by Life 
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Dental caries and periodontal disease are two of the most prevalent infectious diseases in 
humans (Bagramian et al., 2009; Dentino et al., 2013). They cause destruction of tooth structures 
and supporting tissues and eventually lead to loss of teeth. To date, dental amalgam and 
composite resin are two major restoration materials for treatment of dental caries. However, the 
physical properties of these two materials are far from comparable to those of true enamel, 
resulting in various adverse consequences of restoration treatment (Sharif et al., 2010a; Sharif et 
al., 2010b). Therefore, producing and using true enamel as a restoration material have been 
aggressively pursued (Nör, 2006). Furthermore, many efforts have been made to regenerate 
whole functional teeth for patients who lose teeth due to extensive tooth decay or periodontal 
disease (Ikeda et al., 2009; Galler and D'Souza, 2011). However, all of these goals can only be 
achieved, based on thorough comprehension of enamel formation and tooth development in 
which the genetic control of these developmental processes has not yet been completely 
understood. 
Human inherited dental anomalies provide a valuable resource for studying tooth 
development (Cobourne and Sharpe, 2013). Discerning the genetic etiology of these 
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developmental defects not only improves our comprehension of normal tooth development but 
also provides a scientific foundation for developing potential preventive and therapeutic 
strategies for these disorders. While tooth agenesis is a tooth-number abnormality that is caused 
by disruptions at early tooth development, amelogenesis imperfecta is a collection of inherited 
enamel defects due to disturbances in enamel formation. Identification of genes associated with 
these two diseases has led to the discovery of many critical players in tooth and enamel 
development (Cobourne and Sharpe, 2013). However, there is still a significant number of cases 
for which genetic defects cannot be found in known disease candidate genes, indicating our 
current incomplete knowledge of the critical molecular participants in tooth and enamel 
formation (Chan et al., 2011; Arte et al., 2013). 
In this thesis, we studied families with tooth agenesis and amelogenesis imperfecta (AI) 
and aimed to define the genetic etiology of the disorder in each family and to discover novel 
disease associated mutations and genes. We applied both target gene approaches and whole 
exome sequencing for mutational analysis. The results for tooth agenesis and AI were described 
in Chapter 2 and 3 respectively. 
For mutational analysis of tooth agenesis, we described 7 families with non-syndromic 
tooth agenesis, in which there was considerable variation in the number and class of teeth that 
were involved. We identified a novel PAX9 mutation (c.43T>A, p.Phe15Ile) in a proband with 
10 missing teeth and two reported WNT10A mutations (c.321C>A, p.Cys107* and c.682T>A, 
p.Phe228Ile) in a family where the compound heterozygotes exhibited severe oligodontia 
without other non-dental OODD phenotypes. However, we were unable to determine the genetic 
defects in other families using target gene approaches of known candidate genes or by 
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comparative whole exome analyses. The results demonstrate a high genetic heterogeneity of 
tooth agenesis and the difficulty of establishing genotype-phenotype correlation in this disorder. 
For mutational analysis of inherited enamel defects, we described 12 AI families with 
various enamel malformations and different patterns of disease inheritance. We successfully 
identified genetic defects in these families. Novel MMP20 (c.611A>G, p.His204Arg) and KLK4 
(c.245delG, p.Gly82Alafs*87) mutations reaffirmed the critical roles of enamel matrix proteases 
in amelogenesis, especially enamel maturation (Hu et al., 2007; Bartlett, 2013). The enamel 
phenotypic heterogeneity of MMP20-associated AI also suggests unrecognized functions of 
MMP20 other than processing and degradation of enamel matrix proteins (Wang et al., 2013b). 
A novel FAM83H mutation (c.1369C>T, p.Gln457*) re-demonstrated the genetic homogeneity 
of FAM83H disease-causing mutations and supported the hypothesis of dominant negative 
effects as the pathological mechanism of ADHCAI. Novel SLC24A4 (c.437C>T, p.Ala146Val) 
and STIM1 (c.1276C>T, p.Arg426Cys) mutations, along with the specific expression of these 
two genes in maturation-stage ameloblasts demonstrated by immunohistochemistry, reveal the 
critical roles of these two Ca2+-transport related proteins in enamel maturation and the important 
differences in the Ca2+ transcellular transport systems employed by secretory and maturation 
stage ameloblasts (Wang et al., 2014b). Furthermore, we identified 7 FAM20A mutations in 5 
families of AIGFS with/without nephrocalcinosis, established FAM20A mutations as a cause of 
Enamel-Renal Syndrome (ERS), and proposed that AIGFS and ERS are the same disease entity 
with variable presentation of renal calcifications (Wang et al., 2013a; Wang et al., 2014a). We 
also reported the first human Integrin beta 6 (ITGB6) mutations causing generalized hypoplastic 
AI, which demonstrates that cell-matrix interaction and integrin signaling are critical for enamel 
formation. The results strongly suggest that amelogenesis is a complicated biological process 
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depending upon extensive cell-cell and cell-matrix interactions, which poses significant 
challenges to the validity of growing enamel crystals “biomimetically” with only selected 
recombinant enamel matrix proteins (Wang et al., 2013c). For many other AI families not 
described in this thesis, we are still not able to identify the genetic causes of their enamel defects, 
which reaffirms the high genetic heterogeneity of AI and revealed our current incomprehensive 
knowledge about enamel formation. 
In addition to finding critical players in tooth and enamel development, researchers also 
aim for defining the functions of many genes identified by human mutational analyses of 
inherited dental anomalies, in order to understand the genetic regulation and molecular 
mechanisms of these developmental processes. Therefore, in this study, we attempted to 
determine the functions of FAM83H, a gene of which the mutations cause ADHCAI, at cellular 
and molecular levels and to unravel the pathological mechanism of FAM83H-associated AI (Kim 
et al., 2008). 
By studying FAM83H protein-protein interaction, we found that FAM83H interacts with 
itself, which suggests that the mutant protein may exert the dominant negative effect through 
interacting with the wild-type protein and prevent it from functioning. We also demonstrated that 
FAM83H interacts with casein kinase 1 (CK1) via an F-X-X-X-F-X-X-X-F sequence motif in its 
N-terminus and with SEC16A via a binding domain in the middle of the protein. Knowing 
SEC16A is involved in ER-to-Golgi membrane trafficking, we proposed that FAM83H may 
serve as a scaffold protein for localizing CK1 to SEC16A so that CK1 can facilitate membrane 
and protein trafficking at the ER exit site, which is an active cellular process during the secretory 
stage of amelogenesis. We hypothesized that truncated FAM83H that can bind to CK1 but not 
SEC16A will disturb localization of CK1, result in altered vesicle trafficking and protein 
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transport, and lead to a pathology in ameloblasts. However, further investigations are needed to 
confirm these potential cellular functions of FAM83H and to substantiate the hypothetical 
mechanism of dominant negative effect mediated pathogenesis of ADHCAI. 
In summary, our group pursued a forward genetics-based approach in this study to 
investigate tooth and enamel development. We identified genes associated with developmental 
tooth defects and investigated the functions of genes in normal developmental processes as well 
as the pathological mechanisms of their associated disorders. By discerning the genetic etiology 
of tooth agenesis and AI through mutational analysis, we reaffirmed and discovered critical 
players in tooth and enamel formation, such as MMP20, KLK4, and ITGB6. For functional 
investigations, we focused on the recently-discovered AI-causing gene, FAM83H, defined a 
potential function of facilitating vesicle and protein trafficking, and tested a hypothetical model 
for the pathogenesis of FAM83H-associated ADHCAI. This phenotype-to-genotype approach, 
although bearing more difficulties for defining gene functions, provides the most relevant way to 
study tooth development. 
 
PROSPECTS 
Human mutational analysis for tooth agenesis has revealed many critical genes and 
signaling pathways in early tooth development (Cobourne and Sharpe, 2013). However, the 
actual roles of these players in tooth formation and the pathological mechanism of their 
associated tooth agenesis are not very clear. This is partly due to the limitations of widely-used 
mouse models for tooth development. Unlike humans with two dentitions, rodents have only one, 
which is analogous to humans’ primary dentition (Jernvall and Thesleff, 2012). However, as 
135 
 
mentioned previously, human tooth agenesis affects permanent (secondary) dentition much more 
frequently than primary dentition (Nieminen, 2009). Also, the developmental molecular 
mechanisms for the formation of two dentitions appear to be different. While primary teeth 
initiate from de novo dental laminae, permanent teeth develop from the dental laminae of their 
predecessor primary teeth (Jernvall and Thesleff, 2012). Therefore, the mouse model is not 
optimal for studying secondary tooth formation and the pathological mechanisms of human tooth 
agenesis. For example, human loss-of-function mutations of LTBP3 were reported to cause 
severe oligodontia and short stature (Noor et al., 2009); however, the Ltbp3 null mice exhibited 
no dental abnormalities (Dabovic et al., 2002), which demonstrates the importance of using other 
animals as a disease model for human tooth agenesis. Pigs have long been used in dental 
research, although mainly for protein characterization of developing teeth (Yamakoshi et al., 
2006). Like humans, pigs have two dentitions, and their dental formulae (I3-C1-M3; I3-C1-P4-M3) 
are similar to those of humans (I2-C1-M2; I2-C1-P2-M3). Thus pigs offer important advantages 
over mice as an animal model for studying tooth number abnormalities. Recently, several 
genome engineering techniques, such as ZFN (zinc finger nucleases), TALENs (transcription 
activator-like effector nucleases), and CRISPR/Cas system, have made it possible to efficiently 
target and edit specific genomic areas in many organisms other than mice (Le Provost et al., 
2010; Joung and Sander, 2013; Mali et al., 2013; Wei et al., 2013), providing an avenue for 
using porcine models to study tooth renewal and human tooth number abnormalities. 
For studying enamel development, scientists have taken advantage of the abundance of 
enamel matrix proteins in developing teeth to structurally and biochemically characterize these 
proteins to gain insights into their potential roles in dental enamel formation (Hu et al., 2007). 
However, investigation of enamel matrix proteins from developing teeth seemed to have been 
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thoroughly explored. With traditional approaches, it is not easy to identify trace amount of 
proteins and low-expressed genes which may also play significant roles in enamel formation 
(Yamakoshi et al., 2006). Therefore, recently, the direction and approaches to study enamel 
formation have been shifted from a biochemical aspect to a genetic aspect, meaning that by 
discerning genetic causes of inherited enamel defects, new critical players for enamel 
development can be identified (Wright et al., 2011; Chan et al., 2011). However, as 
demonstrated in this study, many efforts still need to be made to define the genetic defects of 
many AI cases with unknown etiology. As many mouse models have been shown to phenocopy 
human AI (Gibson et al., 2001; Caterina et al., 2002; Hu et al., 2008; Simmer et al., 2009), 
careful characterization of the dental phenotypes in high-throughput knockout mouse project, 
KOMP (Ayadi et al., 2012), will identify more critical players in enamel formation and facilitate 
human genetic analyses into the causes of enamel malformations through the discovery of new 
candidate genes and the biological validation that defects in specific genes result in enamel 
defects. In other words, both forward-genetics (in humans) and reverse-genetics (in mice) based 
approaches need to be complementarily used to advance the enamel research. Furthermore, 
current knowledge about molecular and genetic regulation of the developmental process of 
enamel formation is fragmentary, mainly based upon the fact that individual gene defects cause 
enamel malformations. Therefore, following the list of AI candidate genes being expanded, more 
efforts need to be made to study gene-gene or protein-protein interactions in enamel formation 
from the perspective of molecular pathways or networks. For example, as mentioned previously, 
SLC24A4, STIM1, and ORAI1 mutations cause hypomaturation AI, and all these genes are 
involved in calcium transport in the cell (Feske et al., 2006; Picard et al., 2009; Parry et al., 
2013). By elucidating how these molecules function cooperatively in ameloblasts, we will be 
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able to understand the underlying mechanism of calcium transport and homeostasis during 
enamel maturation (Wang et al., 2014b). 
Our in vitro molecular characterization of FAM83H suggests a potential cellular function 
of FAM83H and a hypothetical model for the pathogenesis of its associated enamel defects. 
However, these results and hypotheses cannot explain all observations and need to be further 
tested and confirmed by in vivo models. A conventional or conditional knockout (KO) mouse 
model is necessary to define the function of Fam83h in normal enamel development. However, 
in order to study the pathological mechanism of ADHCAI, a disease (truncation) mutation 
knockin (KI) model may be required, since a dominant negative effect from mutant FAM83H is 
suspected to be the pathogenesis of enamel defects. Therefore, our group has generated both 
mouse models, a conventional KO (Fam83h-/-) and a disease mutation KI (Fam83hY297X/Y297X). 
With these two models, we will be able to test the in vitro results we presented here. For 
example, immunostaining of FAM83H and CK1 in KI mice will reveal if the mutant FAM83H 
alters CK1 localization in ameloblasts. Also, primary culture of ameloblasts from both KO and 
KI mice will allow us to conduct ex vivo experiments to define the normal and aberrant functions 
of FAM83H protein at molecular and cellular levels. 
Recently, patient-specific induced pluripotent stem cells (iPSCs) have been used as a 
model to study human diseases, such as neurological disorders (Bellin et al., 2012; Peitz et al., 
2013). Somatic cells harvested from patients are induced into iPS cells, which carry the patient-
specific genetic defect, and re-differentiated into specific disease-affected cells and tissues, such 
as neurons for neurological disorders. These cells can be used not only to study the molecular 
mechanism of disease pathogenesis but also to develop potential therapeutics for the disease. 
This approach is especially valuable for studying diseases in which there is limited experimental 
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access to disease-affected human tissues (Bellin et al., 2012). Ameloblasts are only present 
during enamel development and cannot be obtained following tooth eruption. Therefore, AI 
patient-specific iPS cells may serve as a potential disease model to study aberrant amelogenesis. 
However, although people have reprogrammed mouse iPS cells into “ameloblast-like” cells (Liu 
et al., 2013), significant efforts still need to be made to establish specific protocols to 
differentiate human iPS cells into functional ameloblasts and recapitulate the processes of 
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